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ABSTRACT 
 This study investigates the antitheilerial activity (in vitro) of the 
aqueous extract of four local medicinal plants, Gardenia ternifolia (Abu 
Gawie), Kigelia africana (Abu shutour), Sonchus cornutus (Moleita) and 
Tinospora bakis (Irg al-Hagar).  
 Preliminary screening of the aqueous extracts of the four plants for 
activity against Theileria lestoquardi (ovine theileriosis) was done at 
concentrations of 250, 500, 5000 and 10000 ppm. The antimalarial drug, 
Paluther (Artemether 80), was tested for antitheilerial effect. On the other 
hand, Butalex (buparvaquone) was used as a standard drug.  
 Screening for antitheilerial activity revealed K. africana to be the 
most potent candidate among the studied plants, followed by Gardenia 
ternifolia, and Tinospora bakis. However, Sonchus cornutus lacks activity. 
The highest activity of K. africana, Gardenia ternifolia and T. bakis at 
10000 ppm was 80%, 60% and 30%, respectively; Artemether 80 
producing 45% activity at 10mg/L. But buparvaquone at 10mg/L produced 
100% activity. 
LC50 of K. africana, G. ternifolia and T. bakis was 2660.28 ppm, 
6745.28ppm and 184268.54 ppm, respectively. However, Artemether 80 
and buparvaquone having LC50 of 21.29 mg/L and 0.000015 mg/L, 
respectively. 
 Plant extracts plus Artemether 80 and buparvaquone caused changes 
in the morphology, colour and mean number of macroschizonts. The 
number of cells with extra cellular macroschizonts increased, but the mean 
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number of divided cells (binucleated and multinucleated) and viable cells 
decreased. 
 The four plants, Artemether 80 and buparvaquone caused partial 
cytotoxicity at the highest concentration resulting in changes of the 
morphology of lymphoblast cells and decreasing the number of viable 
cells.   
 
 VX
  ﺺﻠﺨﺴﺘاﻟﻤ  
 ﻤﻥ ﺃﺭﺒﻌﺔ ﻨﺒﺎﺘﺎﺕ ﻤﺤﻠﻴﺔﻟﺘﻘﻴﺩﻴﻡ ﻓﻌﺎﻟﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌﻰ ( ﻨﺎﺒﻴﺏﻷﻓﻰ ﺍ)ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ   
 ،)anacirfa ailegiK(ﻭﺃﺒﻭ ﺸﻁﻭﺭ  ،)ailofinret ainedraG(ﻭﺍﻟﻨﺒﺎﺘﺎﺕ ﻫﻰ ﺃﺒﻭﻗﻭﻯ  .ﻁﺒﻴﺔ
  .)sikab aropsoniT(ﺍﻟﺤﺠﺭﻭﻋﺭﻕ  )sutunroc suhcnoS(ﻭﻤﻭﻟﻴﺘﺎ 
ﺜﺎﻴﻠﻴﺭﻴـﺎ  ﻀـﺩ  ﻤـﻥ ﺍﻷﺭﺒﻌـﺔ ﻨﺒﺎﺘـﺎﺕ ﺃﺠﺭﻯ ﺍﻟﻜﺸﻑ ﺍﻷﻭﻟﻲ ﻟﻔﻌﺎﻟﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌﻰ   
ﺃﻤـﺎ ﻤﻠﻴﻭﻥ /ﺠﺯﺀ 00001ﻭ 0005ﻭ005 ﻭ052ﺒﺘﺭﻜﻴﺯ  (ﺤﻤﻰ ﺍﻟﻘﺭﺍﺩ ﻓﻲ ﺍﻟﻀﺄﻥ)ﻟﻴﺴﺘﻭﻜﻭﺍﺭﺩﺍﻯ 
ﻭﻤـﻥ ﺠﺎﻨـﺏ  0ﺃﺨﺘﺒﺭ ﺘﺄﺜﻴﺭﻩ ﻀﺩ ﺍﻟﺜﺎﻴﻠﻴﺭﻴﺎﻀﺩ ﺍﻟﻤﻼﺭﻴﺎ،  ﻌﻤلﻴﺴﺘﺍﻟﺫﻯ  (08ﺁﺭﺘﻴﻤﻴﺜﺭ ) ﺒﺎﻟﻴﻭﺜﻴﺭ
  .ﺩﻭﺍﺀ ﻤﻌﻴﺎﺭﻴﺎﹰ( ﺒﺎﺭﻓﺎﻜﻭﻥﺒﻴﻭ)ﺁﺨﺭ ﺃﺴﺘﻌﻤل ﺒﻴﻭﺘﺎﻟﻜﺱ 
ﻋﻠﻲ ﺍﻟﻜﺸﻑ ﻀﺩ ﺍﻟﺜﺎﻴﻠﻴﺭﻴﺎ ﺃﻥ ﺃﺒﺎ ﺸﻁﻭﺭ ﺃﻜﺜﺭ ﺍﻟﻨﺒﺎﺘﺎﺕ ﻓﻌﺎﻟﻴﺔ ﻓﻲ ﺍﻟﻘﻀﺎﺀ  ﻨﺘﺎﺌﺞ ﺕﺃﻭﻀﺤ  
ﺃﻋﻠـﻲ ﻓﻌﺎﻟﻴـﺔ  .ﺔ ﻟﻬﺎﻓﻼ ﻓﻌﺎﻟﻴﺃﻤﺎ ﺍﻟﻤﻭﻟﻴﺘﺎ  .ﻋﺭﻕ ﺍﻟﺤﺠﺭﺜﻡ ﺜﺎﻴﻠﻴﺭﻴﺎ ﻟﻴﺴﺘﻭﻜﻭﺍﺭﺩﺍﻯ، ﻴﻠﻴﻪ ﺃﺒﻭ ﻗﻭﻯ 
% 06ﻭ %08ﻤﻠﻴـﻭﻥ /ﺠـﺯﺀ  00001ﻋﻨﺩ ﺍﻟﺘﺭﻜﻴﺯ ﻜﺎﻨﺕ ﺃﺒﻰ ﻗﻭﻯ ﻭﻋﺭﻕ ﺍﻟﺤﺠﺭ ﻭﻷﺒﻰ ﺸﻁﻭﺭ 
ﻭﻟﻜـﻥ ﺒﻴﻭﺒﺎﺭﻓـﺎﻜﻭﻥ  .ﻟﺘﺭ/ﻤﺠﺭﺍﻡ 01ﻋﻨﺩ % 54 ﺒﻠﻐﺕ ﻓﻌﺎﻟﻴﺘﻪ 08؛ ﺁﺭﺘﻴﻤﻴﺜﺭ ﻋﻠﻲ ﺍﻟﺘﻭﺍﻟﻲ% 03ﻭ
  .ﻟﺘﺭ/ﻤﺠﺭﺍﻡ01ﺒﻤﻘﺩﺍﺭ % 001ﺒﻠﻐﺕ ﻓﻌﺎﻟﻴﺘﻪ 
ﺃﺒﻰ ﺸـﻁﻭﺭ ﻟﻜل ﻤﻥ ﻴﺎ ﺍﻟﻠﻴﻤﻔﻭﺒﻼﺴﺕ ﻤﻥ ﺍﻟﺨﻼ% 05ﺍﻟﺘﺭﻜﻴﺯ ﺍﻟﻘﺎﺘل ﻟﻠﻤﺎﻜﺭﻭﺸﺎﻴﺯﻭﻨﺕ ﻓﻲ   
 45.862481ﻤﻠﻴـﻭﻥ ﻭ /ﺠﺯﺀ 82.5476ﻤﻠﻴﻭﻥ ﻭ /ﺠﺯﺀ 82.0662 ﻜﺎﻥ ﺃﺒﻰ ﻗﻭﻯ ﻭﻋﺭﻕ ﺍﻟﺤﺠﺭﻭ
ﻟﺘـﺭ ﻭ /ﻤﺠـﺭﺍﻡ 92.12ﻭﺒﻴﻭﺒﺎﺭﻓـﺎﻜﻭﻥ ﻓﻜـﺎﻥ  08ﻋﻠﻲ ﺍﻟﺘﻭﺍﻟﻲ، ﺃﻤﺎ ﺒﺎﻟﻨﺴﺒﺔ ﻵﺭﺘﻴﻤﻴﺜﺭ  ﻤﻠﻴﻭﻥ/ﺠﺯﺀ
  .ﻟﺘﺭ ﻋﻠﻲ ﺍﻟﺘﻭﺍﻟﻲ/ﻤﺠﺭﺍﻡ 510000.0
 ﻭﻟـﻭﻥ  ﺇﻟﻰ ﺘﻐﻴﺭ ﻓﻲ ﺸـﻜل  ﻯﻭﺒﻴﻭﺒﺎﺭﻓﺎﻜﻭﻥ ﺃﺩ 08ﻴﺜﺭ ﺁﺭﺘﻴﻤﺯﺍﺌﺩﺍﹰ ﻟﻨﺒﺎﺘﺎﺕ ﻤﻥ ﺍﺍﻟﻤﺴﺘﺨﻠﺹ   
ﻭﻟﻜﻥ ﻤﺘﻭﺴﻁ ﻋﺩﺩ ﺫﺍﺕ ﺍﻟﻤﺎﻜﺭﻭﺸﺎﻴﺯﻭﻨﺕ ﺨﺎﺭﺝ ﺍﻟﺨﻠﻴﺔ، ﺍﻟﺨﻼﻴﺎ ﻋﺩﺩ ، ﻭﺯﻴﺎﺩﺓ ﺍﻟﻤﺎﻜﺭﻭﺸﺎﻴﺯﻭﻨﺕﻭﻋﺩﺩ 
  .ﻭﺍﻟﺨﻼﻴﺎ  ﺍﻟﺤﻴﺔ ﻗﺩ ﻨﻘﺹ  (ﺫﺍﺕ ﺍﻟﻨﻭﺍﺘﻴﻥ، ﺃﻜﺜﺭ ﻤﻥ ﻨﻭﺍﺘﻴﻥ)ﺍﻟﺨﻼﻴﺎ ﺍﻟﻤﻨﻘﺴﻤﺔ 
ﻟﺨﻼﻳѧѧﺎ اﻟﻠﻴﻤﻔﻮﺑﻼﺳѧѧﺖ ﻋﻨѧѧﺪ  ﻴѧѧًﺎﺟﺰﺋ ًﺎﻤﺗﺴѧѧﻤ ﻮاوﺑﻴﻮﺑﺎرﻓѧѧﺎآﻮن ﺳѧѧﺒﺒ 08اﻷرﺑﻌѧѧﺔ ﻧﺒﺎﺗѧѧﺎت وﺁرﺗﻴﻤﻴﺜѧѧﺮ   
 .ﺗﻐﻴﺮ ﻓﻰ ﺷﻜﻞ اﻟﺨﻼﻳﺎ وﻧﻘﺼﺎن ﻋﺪد اﻟﺨﻼﻳﺎ اﻟﺤﻴﺔﻧﺘﺞ ﻋﻨﻪ أﻋﻠﻲ ﺗﺮآﻴﺰ 
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INTRODUCTION 
 Parasites of Theileria species infect wild and domestic 
animals in the tropical and subtropical regions of the world.  
Bovine theileriosis in cattle worldwide has been extensively 
studied, but a paucity of information exists concerning ovine 
theileriosis. Recently, interest has arisen in sheep infected with 
theileria parasites. Among these, Theileria lestoquardi (formerly 
T. hirci) and the newly described Theileria species (China) are 
considered to be highly pathogenic (Hooshmand-Rad and Hawa, 
1973; Jianxung and Yin, 1997). The other species, such as T. ovis 
and T. separata are less pathogenic and have lower economic 
importance than T. lestoquardi (Uilenberg, 1981; Alani and 
Herbert, 1988). 
 T. lestoquardi (Morel and Uilenberg, 1981) is a tick-borne 
protozoan parasite of sheep which occurs in South eastern Europe, 
Northern Africa, Western and Central Asia (Uilenberg, 1981) and 
in India (Sisodia, 1981). Theileria lestoquardi causes malignant 
theileriosis in sheep and goats which may be acute, subacute or 
chronic. Theileria lestoquardi is transmitted by Hyalomma 
anatolicum anatolicum (Hooshmand-Rad and Hawa, 1973a).  
Recently malignant theileriosis has been considered to cause great 
losses in sheep flocks in Khartoum State (Nagwa, 1986; Tageldin 
et al., 1992). The prevalence rates of T. lestoquardi antibodies in 
Sudanese sheep from nine geographical areas in Sudan ranged 
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from 23.4% in River Nile state to 10% in Kasala and Darfur 
provinces with an overall prevalence of 16.2% indicating 
widespread distribution of infection (Salih et al., 2003). 
 Theileriosis constitutes a real hazard to livestock and 
development plans. It would be a waste of effort and resources 
to import exotic breeds or implement ambitious cross-breeding 
programs without control of ticks. 
 Treatment of theileriosis is mainly by use of potent anti-
theilerial drugs; parvaquone and buparvaquone; which are 
expensive (Shastri, 1989; Dhar et al., 1990; Singh et al., 1993).  
These drugs are not usually available in third world countries, 
because of financial constraints. Thus, it is desirable to find 
remedies, which are effective, cheap and readily available as may 
be availed by plant extracts of relevant putative activity. 
 Prior to discovery of organic chemistry in the 19th century, 
80% of all medicines were obtained from plant materials.  In 
Africa, herbal medicine is particularly popular and it is estimated 
that 80% of the population resort to traditional medicine to treat 
human and livestock diseases (Ole-Miaron, 2003). 
Natural products have traditionally been the most common 
source of drugs, and represent more than 30% of the current 
pharmaceutical market (Kirkpatrik, 2002).   Natural products are 
still major sources of innovative therapeutic agents for infectious 
diseases (bacterial, parasitic and fungal), cancer, lipid disorders 
and immunomodulation (Altmann, 2001). 
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 Herbalists in the Sudan as well as in other parts of the 
world commonly treat recurrent fevers similar to malaria with 
herbal remedies.  Related blood parasites are also of extreme 
importance and cause economic losses to livestock. As for 
theileriosis, which occurs in cattle, sheep, goats and other animals, 
treatment with effective herbal remedy from some medicinal 
plants in Sudan might provide medical and economical benefit. 
Hence the present attempt of elucidating likely therapeutic 
benefits of some indigenous plant extracts hereto. 
The Objective of the study: 
1. Preparation of cell culture of theileria infected lympho-
cytes. 
2. Screening of plant aqueous extracts for their therapeutic 
activity on parasite cell culture. 
3. Cytotoxicity of plant aqueous extracts. 
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CHAPTER ONE 
LITERATURE REVIEW 
 
 The most widely used method for the control of theileriosis 
is chemical control of vector ticks with acaricides.  However, tick 
control has become less reliable because of acaricide resistance, 
the high cost of acaricides, poor management of tick control and 
illegal cattle movement in many countries (OIE Manual, 2008).  
Vaccination using attenuated schizont-infected cell lines has been 
widely used for Theileria annulata, while a method of infection 
and treatment using ground-up infected ticks as stabilate and 
tetracycline treatment is being implemented in a number of 
countries in East and Central Africa for T. parva control 
(Hashemi-Fesharki, 1988; Radley, 1981).   
 Chemotherapy is also widely used. Parvaquone and 
halofuginone are used to treat T. parva and T. annulata, and 
recently an even more effective drug (buparvaquone) has been 
used (Norval et al., 1992). 
 Levine et al. (1980) classified theileria organisms as 
follows: Phylum (Apicomplexa), Class (Piroplasmida), Family 
(Theileridae), Genus (Theileria); and recently two genera, 
haematoxenus and cytauxzoon were recognized in wild game in 
Africa. Apicomplexan parasites are a large phylum of unicellular 
and obligate pathogens, intracellular organisms of great medical 
importance. They include the human pathogens plasmodium 
species, the causative agent of malaria. They also include 
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parasites of veterinary importance that cause considerable 
economic losses such as Theileria species (Basso et al., 2005). 
Theileria are obligate intracellular protozoan parasites, which 
infect both wild and domestic animals throughout the world. They 
are transmitted by ixodid ticks and have complex life cycle in 
both vertebrate and invertebrate hosts (OIE Manual, 2008).  
There are six Theileria species which infect cattle, the most 
pathogenic and economically important are T. parva, causing East 
Coast fever (ECF) and T. annulata, causing tropical theileriosis. 
T. orientalis, T. taurotragi and T. mutans generally cause no or 
mild disease and T. velifera is non-pathogenic, but they are 
common and complicate the epidemiology of theileriosis in cattle.  
The species T. lestoquardi and T. ovis are the main species of 
Theileria in sheep. 
1.1. Antitheilerial chemical drugs: 
 Hawking (1958) used in vitro screening to test forty com-
pounds including antimalarial, trypanocides and antibiotics in the 
concentration of (0.01-10mg/100ml), (0.1-5mg/100ml) and (3-
10mg/100ml), respectively for chemotherapeutic activity against 
T. annulata. No activity was discovered in these compounds. 
Neitz (1959) reported that many trials have been made involving 
testing the efficacy of about fifty protozoacidal and bacteriocidal 
compounds. The results were often inconsistent and contradicting. 
Barnett (1968) reported that since the erythrocytic 
piroplasm and schizont stages respond differently to different 
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drugs, suitable compounds or combination of compounds having 
effects on both stages (Piroplasm and schizont) are needed. 
1.1.1. Diminazene aceturate (Berenil): 
Berenil is an active trypanocide, babesiocide and bacter-
icide, acting directly on the parasite. Its chemical structure is 
shown in Fig. 1. 
 
 
 
 
 
 
 
Fig. 1: Chemical structure of Diminazene aceturate 
 
Mahmoud et al. (1956) reported that T. annulata–infected 
cattle and buffalo were cured of the disease by Berenil at doses of 
7-10 mg/kg bodyweight and 10-12mg/kg bodyweight, respectively. 
Schmulevich and Evplov (1958) described the usefulness of 
Berenil for the treatment of T. annulata. However, Lavrent'ev 
(1960) and Marutyan (1960) did not obtain encouraging results 
with Berenil. Gautam et al. (1970) reported that deep intra-
muscular administration of Berenil at 10-15 mg/kg bodyweight 
proved to be effective against T. annulata. Two to three injections 
had to be given in each case to eliminate the infection. 
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1.1.2. Tetracyclines: 
Mode of action of tetracyclines 
 Tetracyclines are bacteriostatic acting by inhibiting the 
protein synthesis by the microorganisms. This is by chelating the 
metallic ions of the enzymes of the bacteria. They inhibit a wider 
range of G +ve and G-ve organisms than penicillin and 
streptomycin and certain protozoa as theileria, as well as rickettsia 
and mycoplasma. 
 Neitz (1957) used considerable numbers of drugs for 
treatment of T. parva.  Aureomycin (Chlortetracycline) was the 
only effective one at a dose of 100 mg/kg bodyweight. Tetracycline 
possessed the same prophylactic properties as aureomycin. 
Terramycine (oxytetracycline) or aureomycin and primaquine 
when administered together at a dose of 10mg/kg bodyweight and 
1ml/kg bodyweight, respectively exerted some effects. Treatment 
of cattle with tetracycline hydrochloride on the first day of 
experimental infection at a dose of 15mg/kg bodyweight suppressed 
the development of fever but failed to cure established cases when 
treatment was commenced on the first day of fever (Brocklesby 
and Bailey, 1962). Wilde et al. (1966) tested 170 
chemotherapeutic agents in East Africa, the therapeutic effects of 
tetracycline administered during the incubation period were 
confirmed, although Wilde (1967) concluded that neither 
oxytetracycline nor chlortetracycline had any significant effect on 
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the course of the disease when administered parentrally at 
10mg/kg body weight. Mugera et al. (1973) found that 43% of 
cattle treated with chlortetracycline recovered from East Coast 
fever at 12.5 -15 mg/kg bodyweight. Also Brown et al. (1977) 
reported that Oxytetracycline at a dose of 15 mg/kg bodyweight 
for five days was effective when administered either on the day 
when the parasites were first detected or administered at onset of 
fever.  
 Schmulevich and Evplov (1958) found that oxytetracycline 
was effective against Therileria annulata infection. Hashemi-
Fesharki and Shad-Del (1974) reported that oxytetracycline had 
no therapeutic value when administered at a dose of 12 mg/kg 
bodyweight, but Singh et al. (1980) found it effective at a dose of 
10-15mg/kg bodyweight for 4-6 days. Treatment with long-acting 
oxytetracycline at 20mg/kg bodyweight had no effect when 
administered either as a single or triple doses, but Bansal and 
Sharma (1986) found it effective at a single dose of 20mg/kg 
bodyweight. Also Bhattacharyulu (1988) found that treatment of 
calves-experimentally infected with T. annulata-with oxytetra-
cycline at a dose of 20mg/kg bodyweight reduced the severity of 
the symptoms of the disease. Spooner (1990) found that oxytetra-
cycline at a dose of 5µg/ml, or higher for 8 days (in vitro) 
completely inhibited the establishment of schizonts and their 
ability to transform host cells infected with T. parva. 
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1.1.3. Primaquine phosphate, sulphamethoxypyrazine, trimetho- 
prim, Suramin (Naganin) and Quinuronium sulphate (Ac- 
aprin): 
Sulphamethoxypyrazine and trimethoprim; Naganin; Acaprin 
were previously used as effective agents against malaria, trypano-
somiasis and babesiosis, respectively (Zhang, 1987). 
Quinuronium sulphate is a compound of quinoline and 
urea.  It is effective against all babesia, but does not completely 
eradicated the parasites. It has potent anticholinesterase activity, 
releases histamine and depresses cellular oxidation.  
Zhang (1987) reported that Primaquine phosphate (C15 H21 
O N3.2 H3 PO4) was effective parasiticide against the gametocytes 
of T. annulata at a dose of 0.75mg/kg bodyweight, but naganin, 
acaprin, and combination of sulphamethoxypyrazine and trime-
thoprim at a dose of 30, 1.37, 100 and 50 mg/kg bodyweight, 
respectively was not effective.  Moreover, all five drugs were not 
effective in eliminating the schizont of T. annulata. Earlier 
reports, such as those of (Antipin et al. 1956) showed that naganin 
at a dose of 15-20mg/kg bodyweight (10%) intravenously 
inhibited the growth of schizont and formation of gametocytes; 
Hutyra  et al. (1959) found that acaprin (5%) was an efficient drug 
causing disappearance of the schizonts in liver and spleen at a 
dose of 5ml/100kg bodyweight subcutaneously. 
1.1.4. Halofuginone (Terit, Hoechst AG): 
Halofuginone bromide (di-trans-7-bromo-6-chloro-3-[3-
(hydroxyl-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone), was 
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identified as effective treatment against clinical and experimental 
infections of T. parva and T. annulata when administered orally at 
1.2 mg/kg bodyweight, and 1.2-2mg/kg bodyweight, respectively 
(Schein and Voigt, 1979; Voigt and Heydorn, 1981). Halofug-
inone lactate was also effective in the therapy of both T. parva 
and T. annulata infections at doses of 1-2mg/kg bodyweight. 
Doses above 3mg/kg bodyweight were toxic to cattle (Schein and 
Voigt, 1981). Njau et al. (1985) found that field early cases of 
East Coast fever were successfully treated with halofuginone 
lactate as a single dose of 1.2 mg/kg bodyweight orally while 
cases at advanced stage required two doses of 1.2 mg/kg 
bodyweight given at about two days intervals. Piroplasms were 
not affected by the drug (Njau et al., 1985). Stewart et al. (1990a) 
reported that splenectomised calves naturally infected with T. 
buffeli were treated with primaquinone phosphate and halofu-
ginone lactate either separately or in combination. When used 
alone neither of the drugs eliminate infection. The most successful 
results were obtained when two treatments of halofuginone 
lactate, at a dose rate of 1mg/kg bodyweight orally and six 
treatments of primaquine phosphate at a dose rate of 2 mg/kg 
bodyweight intramuscularly were administered concurrently. 
Singh et al. (1993) reported that halofuginone lactate given orally 
to calves experimentally infected with T. annulata at a dose of 1.2 
mg/kg bodyweight was effective but caused anorexia, diarrhoea 
and debility.  
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1.1.5. Imidocarb: 
 Imidocarb dihydrochloride administered subcutaneously at 
a dose of 1.2mg/kg bodyweight to Friesian cattle infected with T. 
annulata resulted in clinical improvement within one month of 
treatment (ELAbdin et al., 1976).  Two separate treatments, which 
involved the administration of multiple doses of amodiaquinine 
hydrochloride at 10mg/kg bodyweight orally and imidocarb dipro-
prionate at 3mg/kg bodyweight subcutaneously during clinical 
disease retarded mortality and reduced parasitaemia (Sharma et 
al., 1977). Imidocarb diproprionate at a dose of 1.2mg/kg body-
weight was effective in reducing the parasitaemia in T. sergenti 
infections by about 80% (Purnell and Rae, 1981), but Brocklesby 
(1961) reported that amicarbalideisethionate (3,3 diamidino-
carbanalide di-isethionate) was not effective against T. parva. 
Intramuscular injections of 2mg/kg bodyweight dimidine (imido-
carb) alone or imidocarb with sulphapyridazine (10%) 5mg/100ml 
and demaphocycline 7.5mg/kg bodyweight were effective against 
theileriosis (Divanov, 1982). 
1.1.6.Menoctone: 
 The antimalarial activity of menoctone [2-hydroxy-3-(8-
cyclohexyloctyl)-1,4 naphthoquinone] may be due to the blocking 
of the synthesis of Co-enzyme Q and thereby affecting the 
electron transport system (Peters, 1974). McHardy et al. (1976) 
found that menoctone, had a high level of antitheilerial activity in 
vitro and in vivo at a dose of 1.0 mg/ml and 5mg/kg bodyweight 
 
12 
followed by five daily doses of 1mg/kg bodyweight. Menoctone 
was also effective when administered intravenously at a dose of 
5mg/kg bodyweight and 2.5mg/kg bodyweight on the day of 
infection and then daily for 9 days at 0.5 mg/kg bodyweight or  
0.1 mg/kg bodyweight (Dolan and McHardy, 1978). McHardy 
(1978) screened antimalarial, anticoccidial, antibacterial, other 
antiprotozoals, antimetabolites, anti-inflammatories, antiviral 
agents and other compounds for activity against T. parva and T. 
annulata in vitro. Only two compounds menoctone and 
methotrexate showed significant activity against T. parva at 
concentration of 10-0.001mg/L, and only slightly less effect 
against T. annulata. Activity was maximal at 0.1 mg/L. 
Methotrexate, which interferes with folate biosynthesis showed 
activity about 1% that of menoctone at 10mg/L in vitro. EC50 of 
menoctone was 0.06 mg/L (Boehm et al., 1981). Menoctone was 
effective against experimentally infected calves at dose of 10 
mg/kg bodyweight (Mishra and Sharma, 1989).  
1.1.7. Aminoquinolines:  
Neitz (1950) reported that the 8-aminoquinolines pama-
quine, pentaquine and primaquine affected the piroplasms stages 
of the parasite, and the 4-aminoquinoline chloroquine inhibited 
the schizont stage, although Barnett and Bailey (1957) were 
unable to confirm the effect of chloroquine.  Anjaria et al. (1976) 
reported that the administration of chloroquine phosphate at doses 
of 1200-2800 mg intramuscularly, together with intravenous or 
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intramuscular doses of 3mg of quinine dihydrochloride once daily 
for 4 days provided some beneficial effect in the treatment of T. 
annulata infections in exotic and cross bred cattle.  Resochin 
diphosphate had no therapeutic or prophylactic value in the 
treatment of T. annulata infection (Laiblin and Müller, 1977). 
1.1.8. Parvaquone: 
 Parvaquone (2-cyclohexyl-3-hydroxy-1,4 naphthoquinone; 
993C, Clexon:Welcome) and related cyclohexyl analogues are 
known to be metabolized in mammals via hydroxylation at the 4-
position of the cyclohexyl ring (McHardy et al., 1985). McHardy 
(1979), Dolan (1981) reported the efficacy of parvaquone in the 
treatment of T. parva infection of cattle at a dose of 20 mg/kg 
bodyweight once or 10mg/kg bodyweight twice at 48 hours 
intervals, administered intramuscularly. McHardy et al. (1983) 
confirmed these results using cattle artificially infected with T. 
parva.  Dolan et al. (1984) reported that 71% of cattle recovered 
when treated with parvaquone at 20mg/kg bodyweight. In a 
second experiment the same authors reported that 10mg/kg body 
weight given 48 hours apart were successful in treating 40% to 
90% of animals infected with various T. parva isolates. McHardy 
and Morgan (1985) concluded that total parasitological cure was 
not achieved and symptoms of toxicity were not observed in any 
of the calves experimentally infected with T. parva and inoculated 
with a single dose of 20mg/kg bodyweight or 10mg/kg bodyweight 
twice. Mbwambo et al. (2002) reported that 80% and 93.3% of 
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cattle naturally infected with T. parva were cured with 
parvaquone (Parvexon®) at 10mg/kg bodyweight or parvaquone-
plus-frusemide (Fruvexon®) 5mg plus 1.8mg/kg bodyweight, 
respectively. 
Gill et al. (1981, 1984); Sultan et al. (1981); and Singh et 
al. (1993) showed that parvaquone was effective against T. 
annulata infection at a single dose of 20mg/kg bodyweight.  
Parvaquone injected once at a dose of 20mg/kg bodyweight or 
twice at a dose of 10mg/kg bodyweight at 48 hours intervals cured 
the majority of calves and cattle naturally infected with T. 
annulata (Hawa et al. 1988; Unsuren et al., 1988). Only bulls 
treated with parvaquone (1.0mg/15ml oil suspension) at a dose of 
1ml /kg bodyweight at 48 hours intervals after 14 days of 
experimental infection with T. annulata survived (Stepanova et 
al., 1988). 
1.1.9. Buparvaquone: 
Buparvaquone (BW 720C: Butalex); 2-trans-(4-t-butylcyc-
lohexyl) methyl-3-hydroxy-1,4-naphthoquinone was eight times 
more effective than parvaquone or menoctone in vivo against T. 
parva infection of cattle (Hudson et al., 1985); and McHardy et al. 
(1983). Buparvaquone was twenty times more effective than 
parvaquone when tested in vitro, and its EC50 against T. parva and 
T. annulata was 1x10-9 and 16x10-9 M, respectively; in vivo test 
confirmed the result as buparvaquone cured all cattle infected 
with T. parva and T. annulata at a dose rate of 2.5 mg/kg body 
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weight while parvaquone at a dose of 20 mg/kg bodyweight cured 
90% of cattle (McHardy et al., 1985), but Muraguri et al. (1999) 
concluded that parvaquone and buparvaquone were similarly 
effective as they cured 88% and 90% of cattle naturally infected 
with T. parva at a dose of 10 mg/kg bodyweight twice and 2.5 
mg/kg bodyweight once, respectively. Dhar et al. (1988); Sharma 
and Mishra (1990) found that 71% and 100% of cattle treated at a 
single dose of 2.5 mg/kg bodyweight intramuscularly were cured, 
respectively. But infections of T. buffeli were eliminated from 
68% of calves treated with combination of buparvaquone at 2.5 
mg/kg bodyweight twice, and primaquine phosphate at 2mg/kg 
bodyweight three or six times (Stewart et al., 1990b). Dolan et al. 
(1992); Mishra et al. (1993) concluded that treatment of clinical 
theileriosis with buparvaquone at 2.5mg/kg bodyweight was 
necessary. Alternatively, a single dose of 5mg/kg bodyweight was 
more effective (Singh et al., 1993; Singh et al., 1993a).  
1.1.10. Quinuronium sulphate (Acaprin; Pirevan) and Quinine 
 dihydrochloride: 
Shomein and Obeid (1973) made an experimental treatment 
trial for T. annulata using Pirevan (quinuronium sulphate, 5%) at 
a dose of 3ml/day subcutaneously in all experiments, Pirevan and 
Terramycin (Oxytetracycline hydrochloride, 50mg/ml) at a dose 
of 4ml intramuscularly; combination of Pirevan and Resactin 
(2%) at a dose of 10ml intramuscularly; Quinine dihydrochloride 
injectable solution (3.5mg/ml) was given at a dose of 4ml 
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intramuscularly; combination of Quinine dihydrochloride and 
Resactin was inoculated at a dose of 4ml and 10ml, respectively. 
These drugs failed to suppress the parasite and though it 
disappeared for some times from the peripheral blood circulation, 
they reappeared when animals were subjected to stress.  
 Combination of pirevan and terramycin (Oxytetracyline 
hydrochloride, 50mg/ml) at a dose of 3ml/day subcutaneously and 
4 ml intramuscularly, respectively was not effective against T. 
annulata infection (Shomein and Obeid, 1973). 
 ElGhali et al. (1994) reported that oxytetracycline at 
5mg/kg bodyweight or 10mg/kg bodyweight showed an efficacy 
of 70% and 61.1% against moderate cases of naturally acquired 
malignant ovine theileriosis and overall efficacy of 52.9% and 
55%, respectively. On the other hand, the efficacy and overall 
efficacy of diminazene aceturate at 3.5 mg/kg bodyweight was 
47.1% and 40%, respectively. 
 Taha et al. (1997) treated one of two groups of sheep 
naturally infected with T. lestoquardi with a combination of 
oxytetracycline at 10mg/kg bodyweight and diminazene aceturate 
at 3.5mg/kg bodyweight, respectively. The other group was 
treated with oxytetracycline at 10mg/kg bodyweight and chloro-
quine phosphate at 3.5mg/kg bodyweight. The overall recovery 
rates were 60% and 44% for the combination of oxytetracycline 
and diminazene aceturate; oxytetracycline and chloroquine 
phosphate, respectively. 
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ElHussein et al. (1993) found that 64% of sheep suffering 
from naturally acquired malignant ovine theileriosis recovered 
when treated with buparvaquone at a dose of 2.5mg/kg body-
weight. 
1.2. Antitheilerial herbal drugs: 
 Chandel (1981) reported that garlic extract caused remis-
sion of symptoms and lowered the erythrocytic parasitaemia in 
clinical cases of therileriasis caused by T. annulata. 
 Srivastava et al. (1987) reported that 10ml of 1% garlic 
extract intravenously or 10ml of Neem seed oil extract 
intramuscularly was not effective against T. annulata compared 
with oxytetracycline, which was effective at a dose of 15 mg/kg 
bodyweight. 
Baerts and Lehmann (1991) reported that the results of an 
ethnobotonical survey conducted using questionnaires, on the use 
of medicinal plants-of the region of Cretes Zaire-Nil in Burundi-in 
the treatment of livestock. Theileriosis was the most common 
(18.3%) of the diseases listed and was treated by Hypericum 
revolutum, Clematis simensis, Lantana trifolia, Ocimum basilicum 
and Clerodendrum myricoides. 
 Pradhan (1991) treated calves infected with T. annulata 
with two herbal medicines (acid and water extract) prepared from 
five different indigenous plants commonly found in Orissa 
(India). The extract composed of leaves of Nyctanthes arbor-
tristis, Soymida fibrifuse and Jagadrumis (local name), root of 
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Lawsonia innermis and entire plant of Vitex peduncularis and 
Combretum decandrom. The acid and water extracts were 
administered at a dose of 1ml/20kg bodyweight intravenously and 
1ml/kg orally, respectively. The herbal formulations showed 
potential therapeutic value, compared with combination of Berenil 
and oxytetracycline, which cured clinical cases infected with T. 
annulata at a dose of 16 mg/kg bodyweight and 20mg/kg 
bodyweight, respectively. Aqueous extract of leaves and stem 
bark from Pavetta Schumanniana, which used as indigenous 
remedy for East Coast fever in Southern Tanzania were tested 
against T. parva and T. annulata in vitro. Only marginal 
insignificant schizonticidal effect was detected at levels below 
those toxic to the host cell (Wilkie, 1992). 
Hu et al. (1997) reported that cattle naturally infected with 
T. sergenti, T. annulata, Babesia bigemina and Anaplasma 
marginale, treated with total alkaloid hydrochloride of Peganum 
harmala L. at 5.0mg/kg/day showed a cure rate of 86%, 85%, 
88% and 100%, respectively. The same authors reported that 
harmaline (harmidine) was the most active alkaloid. On the other 
hand, Mirzaei (2007) found that the recovery rate of cattle 
naturally infected with T. annulata and treated with Peganum 
harmala extract at a dose of 5.0mg/kg/day for five days was 78%. 
Ole-Miaron (2003) reported that a survey study was 
conducted on the ethnoveterinary knowledge of the Ilkisonko 
Massai of Kenya. The Massai utilized the plant Olivia volkensi L., 
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roots, leaves and bark of Cissus quadrangularis L., Iboza 
multiflora Benthl E.A. Bruce, and Salvadora persica L; Aloe spp. 
and Plectranthus barbatus Andr.; Croton megalopcarpus Hutch, 
respectively to prepare herbal medicines used in the treatment of 
East Coast fever. 
1.3. Antimalarial herbal drugs: 
 Based on the historical success of natural products as 
antimalarial drugs and the urgent need for new antimalarial, a 
number of South African medicinal plants have been evaluated for 
their antimalarial activities (Pillay, 2008).  
Chemistry, pharmacology and clinical status of herbal 
drugs used to treat malaria had been reviewed (Mukherjee, 1991). 
Although the number of plants used in folklore is quite large, only 
the genera Cinchona, Artemisia, Alstonia and Swertia had been 
found to contain therapeutically significant antimalarial drugs.
 Various attempts had been made to detect and /or isolate 
the active antipyretic or/and antimalarial constituents(s) from 
Azadirachta indica (Ekanem, 1978; Ade-Serrano, 1982; Okpani 
and Ezeukwv, 1981) and Khaya ivorensis and Khaya senegalensis 
(Aldesina, 1983) without any significant result. But Khalid et al. 
(1986) reported that the bark of Khaya senegalensis had been 
used in Sudan and many other African countries as an 
antimalarial. Moreover, Khalid et al. (1986) found that the 
limonoid, gedunin equivalent to quinine extracted from Melia 
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azedarach had an IC50 of about 1µM and 0.3µM after 48 hours 
and 96 hours exposure, respectively against Plasmodium falciparum. 
The activity of Artemisia absinthium aqueous extract on the 
in vitro culture of Plasmodium falciparum at a final concentration 
equivalent to 5g of dry powder of the plant in 50ml of distilled 
water diluted 1:35 showed an 89.8% growth inhibition.  The LD50 
of Sesquiterpene lactone fraction of A. absinthium was 31.4µg/ml 
(Hernandez et al., 1990). 
 Haynes (2001) reported that Artemisinin is the active 
ingredient of the Chinese herb 'qinghaosu' (Artemisia annua) that 
was traditionally used for treating fevers. Artemisia is a well-
known medicinal plant that has been utilized for a number of 
purposes, including malaria, for centuries (Dalrymple, 2006). 
Several semisynthetic derivatives of Artemisinin have been 
used increasingly over the past two decades as antimalarials. 
These derivatives include artemether, arteethers, and artesunate, 
which are all metabolized to dihydro artemisinin, the main active 
agent in the body, are fast acting, and act against gametocytes, the 
sexual stages of plasmodium that infect mosquitoes.  
1.4. Previous work in Gardenia ternifolia: 
1.4.1. Chemical constituents: 
Gardenia ternifolia fruit contains β-amyrin, sterol, fatty 
acids, oleanolic acid, and iridoid glucoside (geniposide) (cited by 
El Ghazali et al., 1983); Tannins (Maiga et al., 2005).  
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Other Gardenia spp. were shown to contain indole 
alkaloides, triterpenes, flavonoids and iridoid glucosides (cited by 
El Ghazali et al., 1983).  
1.4.2. Uses: 
The aqueous extract of the fruits was used for bilharzia, 
whereas that of the roots was used for infective hepatitis and 
splenomegaly (El Ghazali et al., 1987). 
 In traditional medicine, the leaves, fruits and roots were 
boiled and used as an emetic (Maiga et al., 2005). 
1.5. Previous work in Kigelia africana: 
1.5.1. Chemical Constituents: 
 Three major iridoids found in the rootbark and stem of 
Kigelia africana were the catapol derivatives esterified at C-6 and 
these were identified as specioside 2, verminoside 3 and 
minecoside 4 (Akunyili and Houghton, 1993).  Norviburtinal 5, 
generally considered to be a break-down product of the iridoids 
had been isolated from the roots, stembark and fruits. Three 
furanonaphthoquinones kigelinone 7, 2-acetylnaphtho [2-3-b] 
quinone 8 and 2-(1-hydroxyethyl) naphthol [2-3-b] furan 4, 9-
quinone had been isolated from K. pinnata stem and rootbark. 
Three  monoterpenoid-naphthoquinone compounds named isopin- 
natal 11, kigelinol 12 and isokigelinol 13 had been isolated from 
the roots and fruits. 
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 The flavonol quercetin 14 and four flavonones luteolin 15 
its 6-hydroxyluteolin 16, corresponding 7-O-glycosides 17, 18 
were isolated from the leaves and fruits of K. pinnata. 
 Three isovoumarins 6-methoxymellien 19, Kigelin 20 and 
6-demethyl kigelin were isolated from the roots of K. pinnata.  
The lignan kigeliol 22 was isolated from the wood and the 
neolignan balanophonin 23 was isolated from the stembark.  The 
common steroids β-sitosterol 24 and stigmasterol 25 had been 
isolated from the bark and root of K. pinnata. Sitosterol 26 was 
isolated from the fruit of K. pinnata. 
 Fatty acids including vernolic, and caffeic acid were also 
isolated from K. africana (Houghton, 2002). 
1.5.2. Biological activity: 
Most of the studies on the biological activity and chemical 
constituents of K. africana (K. pinnata) have been connected in 
some way or another to its traditional uses.  
Akunyili et al. (1991) conducted at the University of 
Nigeria in conjunction with Chelsea Pharmacy Department, 
London, in vitro tests for the efficacy of the aqueous extract of 
stembark of two major iridoids (Specioside 2 and minecoside 4) 
and naphthoquinones from Kigelia africana against Bacillus 
subtilis, Escherichia coli, Psuedomonas aeruginosa, Staphylo-
coccus aureus and Candida albicans.  Their conclusion was that 
the extract tested had pronounced inhibitory effect against all 
microorganisms. These tests gave validity to the traditional use as 
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a natural antibacterial and antifungal agent. Binutu et al. (1996) 
reported that Kigelinone 7 and isopinnatal 11 were the most active 
compounds with minimum concentration not less than 50 µg/ml 
against any other the bacteria or yeast tested. 
 The ethanolic extract of K. africana bark and fruits at 100 
mg/kg bodyweight gave significant 54% anti-inflammatory effect 
on rats 
Naphthoquinones exhibited antiprotozoal activity against 
Trypanosoma brucei (associated with Sleeping Sickness), Leish-
mania major (associated with Leishmaniasis) and Plasmodium 
falciparum (causative agent of malaria). In all cases of the plant 
material the greatest activity of the extract fractions was shown by 
2-(1-hydroxyethyl) naphtho (2, 3-b) furan 4 with isopinnatal 11. 
(Moideen et al., 1999 and  Weenen et al., 1990).   
Norviburtinal 5 has a reasonable good level of activity 
against melanoma, renal carcinoma and colon cancer cell lines 
(Houghton et al., 1994). 
Kigelia africana rich in flavonoids and saponin, which 
clinically improve firmness and elasticity of the skin between 50-
70%. Clinical studies also showed its effectiveness against 
eczema and psoriasis (Majoe, 2001). 
1.5.3. Cytotoxicity: 
 Studies were consequently initiated testing K. africana 
extract for cytotoxicity against melanoma and carcinoma cell lines 
(Houghton et al., 1994). Khan and Mlungwana (1999) ascribed 
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some in vitro cytotoxicity to sitosterol 26, which was extracted 
from K. africana fruits. Iridoides and naphthoquinones had 
considerable in vitro cytotoxicity (Jackson et al., 2000).   
1.5.4. Uses: 
Kigelia africana has a long history of use by rural African 
communities, particularly for its medicinal properties. Most 
commonly traditional healers have used the sausage tree to treat a 
wide range of skin ailments, from fungal infections, boils, 
psoriasis and eczema, through to the more serious diseases, such 
as leprosy, syphilis and skin cancer. It also has internal 
applications, including the treatment of dysentery, ringworm, 
tapeworm, post-partum haemorrhaging, malaria, diabetes, pneu-
monia and toothache (Houghton, 2002). 
1.6. Previous work in Sonchus cornutus: 
1.6.1. Biological activity: 
 Sonchus cornutus was used as herbicide (Braun et al., 
1991).  
 Other spp. such as S. arvensis was effective against 
microorganism. It was also effective against several fungi, 
viruses, and bacteria (Lemna and Messersmith, 1990). It was used 
as spray with glyphosphate or triclopyr, a selective broad leaf 
herbicide. 
1.6.2. Composition: 
 The leaves (dry weight/100g) of Sonchus oleraceus 
contains protein 28g, fat 4.5g, carbohydrate 45g; calcium 
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1500mg, phosphorous 500mg, iron 45.6mg; vitamin A 35mg, 
Thiamine (B1) 1.5 mg, Riboflavin (B2) 5mg, Niacin 5mg and 
Ascorbic acid (vitamin C) 60 mg (Morris, 2004). 
1.6.3. Chemical constituents: 
 Oliveira et al. (2002) reported that preliminary phyto-
chemical tests showed that polyphenols, steroids, saponins and 
flavonoides were the most abundant constituents in Sonchus 
oleraceus.  
Apigenin, luteolin, quercetin-3-O-glucose, 3-hydroxy-12 
en-ursolic acid, (P-methoxyphenyl) acetic acid and (P-hydroxy-
phenyl) acetic acid were isolated from the acetone extract of S. 
oleraceus (Ying et al., 2005). 
1.6.4. Biological activities and uses: 
The plant is emmenagogue and tonic (Moerman, 1998). 
Duke and Ayensu (1985) reported that an infusion of S. oleracus 
was used to treat diarrhoea, and the latex in the sap was used for 
treatment of warts. The same authors reported that it had 
anticancer activity, the stem juice is a bitter tonic for the deficient 
patient with a sluggish liver. The leaves were applied as a poultice 
to inflammatory swellings (Grieve, 1984). The infusion of the 
leaves and roots was used as febrifuge (Chopra et al., 1986). The 
plant aqueous extract showed its antibacterial activity against 
Staphylococcus aureus, Mycrococcus luteus, Bacillus subtilis, 
Escherichia coli, Pseudomonus aeruginosa and Salmonella 
typhimurium (Oliveira et al., 2002). 
 
26 
In Sudan and Turkey S. oleraceus was used as tonic 
(Leonard, 2007). The latex in the stem was used for commercial 
exploitation as it contains 0.14% rubber (Duke and Ayensu, 
1985). 
Sonchus oleraceus is mild toxic as it may contain large 
quantities of nitrates (Leonard, 2007).  
Four new eudesmanolides were isolated from the whole 
plant of S. transcaspicus that showed antibacterial activity against 
Escherichia coli and Staphylococcus aureus. They also showed in 
vitro cytotoxic activity against cultured human hepatoma, Hela 
(human cervical carcinoma) and murine melanoma cells (Han et 
al., 2005).   
1.7. Previous work in Tinospora bakis: 
1.7.1. Chemical constituents: 
 Palamtine isoquinoline alkaloid was isolated from T. bakis 
(Oliver-Beaver, 1968). 
1.7.2. Biological activity and uses: 
  Lyophilised aqueous extract of T. bakis roots at concen-
trations ranged from 1mg to 4mg/ml showed hepatoprotective 
properties before and after intoxication–by carbon tetrachloride-of 
hepatocytes isolated from rats. This was evaluated by significant 
decrease in the levels of lactate dehydrogenase (LDH) and 
asparate aminotransferase (ASAT) intracellular enzymes (Diallo-
Sall et al., 1997). 
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Lyophilized aqueous extract of T. bakis roots when 
administered at a dose of 4mg/ 100g of weight to cholestatic 
wistar rats showed choleretic effect on biliary acid and /or 
glutathione concentration (Diallo-Sall et al., 1999). Another study 
using syrup of aqueous extract of T. bakis roots maintained its 
choleretic activity when used at a dose of 7.5 mg/100g of weight 
and induced significant increase of biliary secretion in healthy and 
cholestatic rats (Thioune et al., 2002).  
Lyophilized aqueous extract and alkaloidal totum (basic 
form) of T. bakis (Miers) roots when administered orally to 
hyperthermic rabbits at doses of 300 and 600 mg/kg bodyweight, 
2.5 and 10mg/kg bodyweight, respectively, showed significant 
antipyretic effect as compared with Acetylsalicylic acid (Aspirin) 
as reference product (Zafinindra et al., 2003). Quattara et al. 
(2006) reported that T. bakis is a plant of folk medicine used by 
healers in Burkina Faso for the treatment of malaria.  Alkaloidal 
extracts from the roots of T. bakis was active against Plasmodium 
falciparum chloroquine resistant strain W2 in vitro (50µg/ml). 
The maceration of the roots were used for headache 
(ElGazali et al., 2003). 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1. Isolation of Theileria lestoquardi: 
 Separation of infected lymphocytes using gradient method 
with Ficoll-paque was carried out according to the FAO method 
(1984).  
2.1.1. Medium: 
 The stock medium (5X) GMEM with glutamine (Glasgow 
minimum essential medium, Sigma Chemical Co., St. Louis, 
U.S.A.) was prepared at concentration of 62.85 g/L. From GMEM 
(5X), the stock medium (1X) was prepared and composed of 
GMEM (5X) 200ml/L, yeast extract, 1% (Difco, Becton, 
Dickinson, France, S.A.) 25ml/L, lactalbumin hydrolysate, 5% 
(Difco, Becton, Dickinson, France, S.A.) 25ml/L, tryptose 
phosphate broth, 2.95%  (Sigma Chemical Co., U.S.A.) 50ml/L, 
sodium bicarbonate, 0.75% (Riedel-de-Haëm AG., D. 3016 
Seelze 1) 7.5ml/L, double distilled water 738.5ml/L, benzyl 
penicillin sodium, 2x106 I.U./10ml D.D.W (North China Pharma-
ceutical group corporation) 1ml/L, Streptomycin as sulphate, 
1g/13.5ml D.D.W. (Shijiazhuang No. 2 Pharmaceutical factory, 
China) 1ml/L and nystatin 50 I.U. /ml (Sigma Aldrich Chemie, 
Gmbh, Germany), 1m/L. 
 The working medium was composed of GMEM (IX) plus 
Hepe’s buffer (20mM) and young calf serum (20%). 
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2.1.2. Blood: 
Peripheral blood (10ml) was collected in a heparinized 
vacutainer from a young lamb (6 month of age) naturally infected 
with Theileria lestoquardi transported in a cold condition from 
Atbra Veterinary Research  Regional Laboratory. 
2.1.3. Procedure: 
 Heparinized blood (3ml) was diluted with an equal volume of 
GMEM (3ml). Diluted blood (3ml) was layered in a sterile test 
tube containing 3ml of Ficoll-paque medium (lymphocyte 
separation medium, aqueous solution of Ficoll 400 and sodium 
diatrizoate, density 1.077g/ml, Seromed®, Germany). The tube 
was stoppered and spinned at 400g (1700 r.p.m.) for 30 minutes in 
a refrigerated centrifuge (Bhernile Gmbh Co., Germany). Three 
layers resulted from the centrifugation, an upper transparent layer 
of plasma, a thin opaque layer containing lymphocytes (buffy 
coat) and the ficoll layer containing red blood cells.  Using a 
sterile pasteur pipette and bulb, the upper layer was aspirated and 
discarded.  Using another pasteur pipette the lymphocytes layer 
was aspirated without disturbing the lymphocyte separation 
medium and transferred to a sterile test tube containing GMEM 
(3ml). The test tube was spinned at 1700 r.p.m. for 10 minutes. 
The supernate was discarded and the cell pellet was resuspended 
in culture medium (1ml). 
 The cell suspension (1ml) was transferred to Falcon tissue 
culture flask (25 cm2) (Sigma Chemical Co. Ltd., Fancy Road, 
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Pod, U.K.) containing 4ml of working medium, marked with T. 
lestoquardi, primary culture and the date. The flask was examined 
under inverted microscope (Hund Gmbh Wllheium, Wetzlar, 
Wilovert 30, Germany). Bright, refractile, round intact cells were 
seen.  The flask was incubated at 37oC. 
 The colour of the medium and microscopic appearance of 
the cells were observed daily.  When the colour of the medium 
became yellowish and the number of cells increased, the medium 
was changed. The cell suspension was transferred to a sterile 
centrifuge tube and spinned at. 900 r.p.m. for 5 minutes in 
refrigerated centrifuge. 
 The supernatant was discarded and fresh medium (1ml) was 
added to the pellet and pipetted gently.  The cell suspension (1ml) 
was transferred to the same flask containing fresh medium (9 ml).  
The flask was examined microscopically.  The change of medium 
was done till the number of cells became 106 cells/ml., then the 
culture was subcultured in the ratio 1:2. When the number of flasks 
was four, two flasks were used for cryopreservation. 
2.2. Cryopreservation of T. lestoquardi cell culture: 
 Freezing was used for banking theilerial isolates for 
serology and future use. 
 The cell suspension containing 106 cells /ml was spinned at 
900 r.p.m. and the cell pellet was resuspended in culture medium 
(2ml). The cells were counted using Neubauer haemocytometer 
(Fein optic Blankburg, G.D.R.) [to obtain a concentration of 106 
cells /ml]. Cells were resuspended in culture medium containing 
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Dimethyl sulphoxide (DMSO), Q-biogene, Deutschland, North 
America, 10%, and young calf serum 10%. The cell suspension 
containing 106 cells /ml was dispensed (1.5ml) into 2ml cryogenic 
vials (Nalgene Cryoware, Nalge Company, U.S.A.). The cryovials 
were closed, labelled with T. lestoquardi, passage and date,  and 
placed at 4oC for 30 minutes, then at (-20oC) for 4 hours. The 
cryovials were then transferred quickly to the liquid nitrogen 
vapour overnight. Then put in the canister and slowly the canister 
was immersed in liquid nitrogen. 
 
2.3. Plant material: 
Four medicinal plants, Gardenia ternifolia, Kigelia 
africana, Sonchus cornutus and Tinospora bakis were collected 
and identified by the staff of the Medicinal and Aromatic Plants 
Research Institute and the Herbarium specimens were deposited at 
the Herbarium of the Medicinal and Aromatic Plants Research 
Institute, National Centre for Research, Khartoum, Sudan. The 
four plants were screened for discovery of their antitheilerial 
activities.  
 
2.3.1. Gardenia ternifolia Schum and Thonn. 
 Gardenia ternifolia; Abu Gawie (Ar.), belongs to the family 
Rubiaceae was collected from Eastern Nuba Mountains.  
2.3.1.1. Description of Gardenia ternifolia: 
 Glarbous shrubs or small trees up to 5m high, leaves opposite, 
ternate or 4-together, obovate, 6-11x3.5-5.4 cm., apex obtuse, base 
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cuneate, margin entire. Inflorescence solitary. Fruit berries, 
ellipsoid, 5-7x2.5-3cm, grey brown. 
Habitat, Khor banks 
Distribution, Central and Southern Sudan  
Gardenia ternifolia is shown in Fig. 2. 
2.3.2. Kigelia africana (Lam.) Benth. in Hook., Fl. Nigrit: 463 
(1849). 
Kigelia africana (K. pinnata); Abu Shutour, Umm 
Mashatour (Ar.); Sausage tree (Eng.); Worsboom (Afr.); um 
Vunguta, umfongothi (Zulu); Modukguhlu (North Sotho); 
Muvevha (venda), belongs to the family Bignoniaceae, was 
collected from Nile Street (Khartoum).  
2.3.2.1. Description of Kigelia africana: 
 Large savanna tree up to 15 m high. Leaves imparipinnate 
up to 30 cm long; leaflets 7-9, opposite, sessile to subsessile, 
obtuse, 4-7x1.8-3cm, apex rounded to mucronate, base cuneate, 
margin undulate.  Inflorescence lax panicles, up to 50 cm long.  
Fruit berries, sausage-shaped, up to 50cm long, pale green. 
Habitat, Khor banks 
Distribution,widespread ,Central and Southern Sudan 
Kigelia africana is shown in Fig. 3. 
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Fig. 2: Gardenia ternifolia Schum and Thonn. 
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Fig. 3: Kigelia africana (Lam.) Benth. in Hook 
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2.3.3. Sonchus cornutus Hochst. ex Oliv. and Hiern 
 Sonchus cornutus; Moleita, Malot (Ar.), of the family 
Asteraceae, was collected from Shambat. 
2.3.3.1. Description of Sonchus cornutus: 
Erect, glabrous, glaucous, perennial herb, emerging from a 
ground rosette; white milk-juice, rhizomatous; up to 1.2m high, 
usually around 0.5m. 
Distribution; widespread, and found on Nile bank (South of 
Khartoum), also in Gezira, and Rahad.  
Sonchus cornutus plant is shown in Fig. 4. 
2.3.4.Tinospora bakis (A. Rich.) Miers in Hook., Niger FL: 
215(1849) 
 Tinospora bakis; Mama (Fung); Irg al-Hagar (Ar.), belongs 
to the family Menispermaceae, was collected from Ingassana 
hills, in Eastern South of the Sudan. 
2.3.4.1. Description of Tinospora bakis: 
 Slender glabrous lianes. Branchlets with lenticles.  Leaves 
broadly ovate-triangular 5-8 cm. across, thiny papery, glabrous, 
digitately 7- nerved at base, petiole 2.5-8.0 cm long, slender. Male 
inflorescence axillary  racemose, slender  up to 8 cm long; female 
inflorescences up to 10cm. long.  Fruits drupes, C.6-9x4-5mm. 
Habitat; low plains 
Distribution,  South-eastern Sudan 
Tinospora bakis is shown in Fig. 5. 
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Fig. 4: Sonchus cornutus Hochst. ex Oliv. and Hiern 
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Fig. 5:Tinospora bakis (A. Rich) Miers 
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2.4. Extraction methods: 
 The common method of extracting medicine is through 
maceration or decoction was used (Ole-Miaron, 2002). 
2.4.1. Aqueous extraction of Gardenia ternifolia, K. africana, S. 
 cornutus and T. bakis: 
 Gardenia ternifolia fruits, K. africana stembark, T. bakis 
roots and S. cornutus whole plant, was cleaned, air dried in the 
shade and ground using mortar and pestle. Each coarsely 
powdered plant part was kept in polyethylene containers till used 
at room temperature. The coarsely powdered plant was extracted 
with water for biological studies. 
2.4.2.Preparation of plant aqueous extract: 
 One gram of the powdered part of each plant was poured in 
a conical flask (25 cm3), double distilled boiling water (10 ml) 
was added to the plant, left at room temperature for 8 hours.  The 
macerated plant was filtered through cotton and made up to 10ml 
with double distilled boiling water. The filtrate  sample was 
sterilized through 0.22 µm Millipore filter (Millipore, U.K. Ltd., 
London) by centrifugation at 2000 r.p.m. for 10 minutes. 
 The filtrate, aqueous extract was poured in a sterile test tube 
and labelled as stock containing 100,000µg/ml (100,000 ppm), 
and used immediately. 
 
 
 
 
39 
2.5. Experimental designs: 
 Five main in vitro experiments were performed aseptically, 
under the same conditions.  In each experiment buparvaquone was 
used for comparison as standard drug. Two plates were set up for 
each experiment. 
2.5.1. Determination of the effect of aqueous extract of G. 
 ternifolia, K. africana, S. cornutus and T. bakis against  
T. lestoquardi: 
Dilution of stock aqueous extract of the plants: 
 Serial dilution of the stock aqueous extract of each plant 
was done as two folds, ten folds and two folds to give a final 
concentration of 50,000, 5000 and 2500 ppm, respectively, 
referring to the starting plant material aqueous extract. 
2.5.2. Determination of the effect of Butalex (Buparvaquone)  
against T. lestoquardi: 
Butalex™ 
 Butalex™ (buparvaquone injection); Schering-Plough Animal 
Health, U.K.).  
The chemical structure of buparvaquone is shown in Fig. 6. 
 
 
 
 
 
 
 
Fig.  6: Chemical Structure of Buparvaquone 
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2.5.2.1. Serial dilution of buparvaquone: 
 Butalex (50 mg/ml), 10 µl was pipetted into a sterile bijou 
bottle containing GMEM (5ml) to give a concentration of 
100mg/L. Then ten-fold dilutions were done to give a concen-
tration of 10, 1 and 0.1 mg/L, respectively. 
2.5.3. Determination of the effect of paluther® (artemether 80) 
against T. lestoquardi: 
 Artemether (80mg/ml); FAB/MAN: Kunming Pharma-
ceutical Corporation-Yunnan, China Lic. Cititech-Beijing-China. 
Paluther is available as a solution of Artemether in ampoule for 
intramuscular administration only.  
2.5.3.1. Serial dilution of Artemether 80: 
Artemether 80 (10 µl) was pipetted into a sterile test tube 
containing GMEM (8ml) to give a concentration of 100mg/L.  
Then, ten-fold dilutions were done to give concentration of 10, 1, 
and 0.1mg/L, respectively. 
2.5.4. Preparation of cell suspension: 
 The Falcon culture flask containing T. lestoquardi 
lymphoblastoid cells passage 8 was examined under the inverted 
microscope to observe the viability and morphology of the cells.  
The flask was shaken gently to remove the adherent cells at the 
bottom of the flask. The cell suspension was centrifuged at 900 
r.p.m. for 5 minutes.  The pellet was dispersed with 5ml GMEM 
(1X) and viable cell count was done. 
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2.5.5. Viable cell counts: 
 Viable cell counts was done according to the method of 
Flow Laboratories Catalogue (Flow laboratories limited Irvine, 
Scotland, Ayrshire). Trypan blue (0.1ml) was put in a bijou bottle, 
then cell suspension (0.1ml) was added, mixed gently and small 
amount of the cell suspension was sucked up into a pasteur pipette 
and filled the counting chamber of the haemocytometer.  Dead 
cells which stained blue were ignored, viable unstained cells in 
the 4 large squares were counted and the number of viable cells 
per ml were calculated according to the formula: 
Number of cells per ml diluted suspension = 104n  
                                                                           4 
Number of cells per ml undiluted =  104ny  
                                                              4                                                   
where: 
104= 1/10-4, is the total volume over each large square 
n= total number of cells counted in 4 large squares. 
Y= dilution factor (fold in trypan blue). 
4 = number of large squares. 
 The cell suspension was diluted with GMEM to give the 
required concentration (5x104 cells/ml). Young calf serum (20%) 
and Hepe’s buffer (20mM) was added to the required volume. 
2.6. Antitheilerial screening: 
 Plant aqueous extract of G. ternifolia, K. africana, S. cornutus, 
T. bakis and Artemether 80 were screened for antitheilerial 
activity, compared with buparvaquone. 
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Methodology: 
2.6.1. Screening of plant aqueous extract: 
Cell suspension (2.7ml) was dispersed into each well of the 
6 wells, flat bottom, polystyrene, tissue culture plate (Falcon, 
Corning Glass Works, New York), in which clean sterile 
coverslips were placed. Plant aqueous extract (0.3ml) was added 
separately to one well in each plate according to the serial dilution 
to give a final concentration -referring to the starting plant 
material aqueous extract- of 10000 ppm, 5000 ppm, 500ppm, 250 
ppm, respectively. Double distilled water (0.3ml) was added to 
each of the two control wells. The four plates were sealed with 
sealing tape, examined under the inverted microscope and 
incubated at 37oC for 48 hours.   
2.6.2. Screening of Buparvaquone: 
 Cell suspension (2.7ml) was distributed into the wells of the 
two tissue culture plates.  Then, GMEM (0.3ml) was added to 
untreated control wells, buparvaquone (0.3ml) of 100, 10, 1 and 
0.1 mg/L was added serially to separate wells to give a final 
concentration of 10mg/L, 1mg/L, 0.1mg/L and 0.01 mg/L, 
respectively. The two plates were sealed, examined under the 
inverted microscope and incubated at 37oC for 48 hours. 
2.6.3. Screening of Artemether 80: 
 Cell suspension (2.7ml) was distributed into the wells of the 
two tissue culture plates. Then, GMEM (0.3 ml) was added to the 
untreated control wells, Artemether 80 (0.3 ml) of 100, 10, 1 and 
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0.1mg/L was added serially to the wells to give a final 
concentration of 10, 1, 0.1 and 0.01 mg/L, respectively. The plates 
were sealed with sealing tape, examined under the inverted 
microscope and incubated at 37oC for 48 hours. 
 In each experiment after 24 hours each plate was examined 
to observe the colour of the medium and microscopic examination 
was done. 
 After 48 hours, microscopic observations were done.  The 
coverslips were picked gently and fixed in absolute methanol for 
5 minutes. The cell suspension of the controls and the same 
concentration of plant extract in each well of the two plates were 
pipetted gently and pooled together in a separate tube for viable 
cell counts and preparation of slides.  
Viable cell counts were done twice using trypan blue as 
described before. 
2.7. Preparation of slides: 
The cell suspension was centrifuged at 900 r.p.m. for 5 
minutes and the deposit cells were dispersed in one ml GMEM. 
 Aliquots of thoroughly mixed cell suspension (0.1 ml) was 
cytocentrifuged to deposit cells directly onto the slides at 600 
r.p.m for 5minutes (cytospin 2, Shandon Southern Products Ltd., 
Astmoor, Runcorn, Cheshire, U.K.). 
 Six slides were prepared from control and each 
concentration, air-dried and fixed in absolute methanol for 5 
minutes. 
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 Slides and coverslips were stained with Giemsa stain 
according to the FAO manual (1983) and (1984b), respectively. 
2.8. Parameters: 
 The following parameters were determined in each 
experiment:  
2.8.1. Microscopic description: 
Description of macroschizonts 
a) Colour of the schizont. 
b) Morphology of the schizont. 
c) Size of the schizont. 
2.8.2. Mean number of lymphoblast cells with dead macrosch- 
izonts; out of 50 cells 
2.8.3. Mean number of alive and dead macroschizonts per cell, 
 in ten untreated control and ten treated cells, respectively. 
2.8.4. Mean number of lymphoblast cells with extra cellular  
  macroschizonts. 
2.8.5. Mean number of divided cells. 
2.8.5.1. Mean number of binucleated cells 
2.8.5.2. Mean number of multinucleated cells. 
2.8.6.Mean number of  viable cells. 
2.9. Cytotoxicity: 
Definition of cytotoxicity: 
 Cytotoxicity is the quality or state of being toxic to cells 
(http/wickicytotoxicity, 2008). 
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 In vitro cytotoxicity was determined as described by 
(http/wickicytotoxicity, 2008). 
1- Microscopic examination. 
2- Viable cell counts. 
2.10. Serology: 
 Indirect fluorescent antibody ‘IFA’ test as described by 
Salih et al. (2003) was used for confirmation of the isolate as 
Theileria lestoquardi. 
2.10.1. Antigen preparation: 
 The schizont antigen was prepared from cryopreserved T. 
lestoquardi cell line at passage 8 according to the method 
described by FAO (1984a) in 12-well Teflon-coated multispot 
slides (High veld Biological, USA). Antigen-coated slides were 
individually wrapped in tissue paper and packed in aluminium foil 
with five slides in each packet. The slide packets were labeled and 
stored in airtight, waterproof plastic container at –20oC until used.  
2.10.2. Conjugate: 
 Rabbit anti-sheep immune-gammaglobulin (IgG) conjugated 
to fluoresein isothiocyanate (FITC) was obtained from Nordic 
immunological laboratory, the Netherlands. 
 The conjugate was used at dilution 1:80 in phosphate buffer 
saline (PBS). Evans blue was added to the conjugate as a counter 
stain at a concentration of 0.01%. 
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2.10.3. Control sera: 
Positive control sera was obtained from Razzi Institute, 
Iran. Negative Control sera was obtained from BDSL, U.K. 
Positive and negative control sera were diluted directly to 
1:80. 
Examination was carried out using Olympus Vanox 
incident-light excitation fluorescent microscope (Japan). The slides 
were examined under 40 x objective using amount as composed 
of nine parts glycerol and one part phosphate buffer saline (PBS). 
2.11. Statistical analysis 
The data were analyzed using the computer program SPSS 
(Statistical Packages for Social Science) Version: 10 for Windows 
Products (SPSS Inc., 233 South Wacker Drive, 11th Floor, 
Chicago 1L60606-6307). The significant difference (using 
ANOVA test) were considered at P<0.05 
The LC50 and LC99 were calculated using the linear 
regression equation Y = a + b x  
Where:  X is the log transformation of the concentration 
used. 
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CHAPTER THREE 
RESULTS 
3.1. Microscopic description: 
 In all experiments the lymphoblast cells (infected 
transformed lymphocyte cells) were found at the periphery of the 
slides and coverslips. The lymphoblast cells were larger than 
lymphocytes (non-infected cells) which were found at the centre 
of slides and coverslips. 
 The control lymphoblast cells were intact with pink, large 
nucleus that occupied large part of the cytoplasm. 
 The macroschizonts in control lymphoblast cell were pink 
in colour, recognizable, regular, normal in size as shown in Fig. 7. 
3.2. Definition of LC50 and LC99: 
LC50 is the concentration of each compound, which reduces 
the proportion of the lymphoblast cells containing a viable 
theileria macroschizonts to 50 percent of that in untreated control 
cells. 
LC99 is the concentration of each compound which reduces 
the proportion of lymphoblast cells containing a viable theileria 
macroschizonts to 99 percent of that in untreated control cells. 
3.3. Effect of Buparvaquone against T. lestoquardi: 
3.3.1. Microscopic description: 
 The dead macroschizonts at concentrations 0.01, 0.10, 1.00 
and 10.00 mg/L were dark in colour, unrecognizable, necrotic 
with loss of structure as shown in Fig. 8. 
 
48 
 
 
 
 
 
 
 
 
 
Fig. 7:Theileria lestoquardi untreated control lymphoblast cell with  
pink, recognizable, regular and normal  macroschizonts 
 Giemsa stain (X1000) 
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Fig. 8:Lymphoblast cell with dark, unrecognizable 
        necrotic macroschizonts with loss of structure 
after 48h exposure to Buparvaquone 
Giemsa stain (x1000) 
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3.3.2. Activity of Buparvaquone against T. lestoquardi: 
 The activity of buparvaquone against T. lestoquardi 48h 
after exposure increased significantly (P<0.05) at concentrations 
0.01, 0.10, 1.00 and 10.00 mg/L as compared with untreated 
control (Table 1 and Fig. 9) being 74, 83.66, 92 and 100%, 
respectively. 
 LC50 and LC99 of buparvaquone were 0.000015mg/L and 
6.92mg/L, respectively were calculated from the linear regression 
line equation (Fig. 10)  
3.3.3. Mean number of macroschizonts per cell: 
 The mean number of macroschizonts is shown in Table 2. 
The mean number of macroschizonts in the untreated control 
lymphoblast was 21.23±0.14 while that in the treated lymphoblast 
cells decreased significantly (P<0.05) at concentrations 0.01, 0.10, 
1.00 and 10.00mg/L (18.65, 18.08, 17.28 and 16.57), respectively.  
3.3.4. Mean number of lymphoblast cells with extra cellular  
macroschizonts: 
 The mean number of lymphoblast cells with extra cellular 
macroschizonts increased significantly (P<0.05) at concentrations 
0.01, 0.10, 1.00 and 10.00 mg/L (3.5, 4.17, 5.5 and 7.5), 
respectively, compared with the untreated control lymphoblast 
cells which has mean value of 2.5± 0.55 (Table 2). 
3.3.5. Mean number of divided cells: 
The mean number of divided cells (binucleated and 
multinucleated) treated with buparvaquone at concentrations 0.01,  
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Table 1: Activity of Buparvaquone against Theileria 
              lestoquardi(m±SD) 
Concent. 
mg/L 
No. of cells 
with dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
Log con. 
0.00 0.00±0.00 50.00±0.00 0.00±0.00 α 
0.01 37.00±0.75* 13.00±0.89* 74.00±1.79* -2.0 
0.10 41.83±0.75* 8.17±0.75* 83.66±1.51* -1.0 
1.00 46.00±0.89* 4.00±0.89* 92.00±1.79* 0.0 
10.00 50.00±0.00* 0.00±0.00* 100.00±0.00* 1.0 
 
* The difference is significant at the 0.05 level 
Linear regression line (Fig. 10): log con. 
Linear regression equation: 
Y = a + b x 
Where, 
a = constant 
b = slope 
x = log dose concentration 
y = 91.733+8.633x 
x=(y-a)/b 
Log LC50 = (50-91.733)/8.633=-4.83 
Antilogy LC50 = LC50 
LC50 = 0.00001479=0.000015mg/L  
Log LC99 = (99-91.933)/8.633=0.84 
LC99 =6.92 mg/L 
: No. of cells with dead macroschizonts (%) 
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Fig. 9: Activity of  Buparvaquone against T. lestoquardi 
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Fig. 10: Linear regression line of Buparvaquone 
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0.10, 1.00 and 10.00 mg/L was decreased significantly (P<0.05) 
as compared with untreated control (Table 2). 
3.3.6. Mean number of viable cells: 
 The mean number of viable cells (untreated control) at 0 
time was 5x104 cells/ml, 48h after incubation increased to  
6.25x104 cells/ml. The mean number of viable cells 48h after 
exposure to buparvaquone decreased significant (P<0.05) at 
concentrations 0.01, 0.10, 1.0 and 10.0mg/L, being 5.5x104, 
5.5x104, 5.0x104 and 4.5x104 cells/ml, respectively (Table 3 and 
Fig. 11). 
3.3.7. Cytotoxicity of Buparvaquone: 
3.3.7.1. Microscopic description: 
  Some of the cells at concentration 10.00 mg/L showed 
cytotoxicity (Fig. 12) with pyknosis and dark chromatin. 
3.3.7.2. Number of viable cells: 
 There was significant (P<0.05) decrease in number of 
viable cells/ml, 48h after exposure to buparvaquone at 
concentration 10.00 mg/L as compared with untreated control 
(Table 3). 
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Table 2: Effect of Buparvaquone on number of macroschizonts / cell, cells with extra  
              cellular macroschizonts  and  divided cells (m±SD) 
Concentration 
mg/L 
No. of 
macroschizonts/ 
cell 
No. of cells with 
extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated  
0.00 21.23±0.14 2.50±0.55 34.00±0.63 17.50±1.05 
0.01 18.65±0.25*  3.50±0.55* 25.67±0.82*  14.17±0.98* 
0.10 18.08±0.10* 4.17±0.75* 20.50±1.05*  10.00±1.26* 
1.00 17.28±0.19* 5.50±0.55* 15.00±0.89*  7.00±0.89* 
         10.00 16.57±0.12* 7.50±0.55* 12.00±0.63*  5.00±1.03* 
 
*The mean difference is significant at the level 0.05
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Table 3: Effect of Buparvaquone on number of viable cells  
               (m±SD) 
Concentration of 
Buparvaquone 
mg/L 
 
No. of cells x 104/ml 
48h before 48 h after 
0.00 5.00±0.00 6.25±0.35 
0.01 5.00±0.00 5.50±0.00* 
0.10 5.00±0.00 5.50±0.00* 
1.00 5.00±0.00 5.00±0.00* 
10.00 5.00±0.00 4.50±0.00* 
 
*The mean difference is significant at the 0.05 level. 
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Fig. 11: Effect of Buparvaquone on number of viable cells. 
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Fig. 12:Lymphoblast cell with pyknosis and dark chromatin after 
48h exposure to Buparvaquone 
Giemsa stain (x1000) 
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3.4. Effect of aqueous extract of Gardenia ternifolia against T.  
lestoquardi: 
3.4.1. Microscopic description: 
 The morphology of the lymphoblast cells and macro-
schizonts 48h after exposure to aqueous extract of G. ternifolia at 
concentration 250 ppm the same as the control. Intact lymphoblast 
cells with intra cellular dead macroschizonts were seen at 
concentrations 500, 5000 and 10000 ppm. The macroschizonts were 
dark in colour, staining character of chromatin was not clear, 
structure of macroschizonts was not clear, unrecognizable and 
necrotic (Fig. 13). 
3.4.2. Activity of queous extract of G. ternifolia against T. 
 lestoquardi: 
 The activity of G. ternifolia aqueous extract against T. 
lestoquardi at concentration 250 ppm, 48h after exposure was zero. 
The activity increased significantly at concentrations 500, 5000 and 
10000 ppm (Table 4 and Fig. 14). 
 LC50 and LC99 of G. ternifolia were calculated from the linear 
regression line equation (Fig. 15). LC50 and LC99 of G. ternifolia 
aqueous extract against T. lestoquardi were 6745.28 ppm and 
177010.90 ppm, respectively.  
3.4.3. Mean number of macroschizonts per cell: 
 The mean number of macroschizonts per cell at con-
centration 250 ppm was the same as the control 21.23±0.12, at 
concentration 500, 5000 and 10000 ppm decreased significantly 
(P<0.05) as compared with the control (Table 5). 
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Fig. 13: Lymphoblast cell showing dark macroschizonts with 
unclear structure after 48h exposure to Gardenia ternifolia 
 Giemsa stain (x1000) 
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Table 4: Activity of aqueous extract of Gardenia 
              ternifolia against T. Lestoquardi (m±SD) 
Concent. 
Ppm 
No. of cells with 
dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
Log con. 
   0 0.00±0.00     50.00±0.00 0.00±0.00 Α 
 250 0.00±0.00     50.00±0.00 0.00±0.00 2.3979 
  500   6.50±0.55*     43.5±0.00* 13.00±1.10* 2.6990 
 5000 20.00±0.63* 30.00±0.00* 40.00±1.27* 3.6990 
10000 30.00±0.89* 20.00±0.00* 60.00±1.89* 4.0000 
 
*The mean difference is significant at the 0.05 level. 
Linear regression line (Fig. 15): Log con. 
y = a + bx 
y = -82.1807+34.5206x 
Log LC50 =(50+82.1807)/34.5206=3.829 
LC50 = Antilog 3.829 = 6745.2803 
LC50 =6745.28 =6745.28ppm 
Log LC99 =(99+82.1807)/34.5206 
LC99 = 177010.8958 =177010.90ppm  
 
 : No. of cells with dead macroschizonts (%) 
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Fig. 14: Activity of aqueous extract of Gardenia ternifolia 
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3.4.4. Mean number of lymphoblast cells with extra cellular 
 macroschizonts: 
 The mean number of lymphoblast cells with extra cellular 
macroschizonts is shown in Table 5, increased significantly 
(P<0.05) at concentrations 5000 and 10000 ppm, the value was 
the same as the control at concentrations 250 and 500 ppm. 
3.4.5. Number of divided cells (binucleated and multinucle- 
ated): 
 The mean number of binucleated and multinucleated 
lymphoblast cells is shown in Table 5. It decreased significantly 
(P<0.05) at concentrations 500, 5000 and 10000 ppm, but not at 
concentration 250 ppm.  
3.4.6. Mean number of viable cells 
 The mean number of viable cells decreased significantly 
(P<0.05) at concentration 500, 5000 and 10000 ppm being 
5.5x104, 4.25x104 and 3.5x104 cells/ml, respectively (Table 6 and 
Fig. 16). 
3.4.7. Cytotoxicity of G. ternifolia 
3.4.7.1. Microscopic description: 
 There was cell debri at concentration 10000 ppm. Some of 
the lymphoblast cells had vacuolated cytoplasm (Fig. 17). 
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Table 5: Effect of aqueous extract of Gardenia ternifolia on number of macroschizonts/  
              cell, cells with extra cellular macroschizonts and number of divided cells (m±SD) 
Concentration 
ppm 
No. of 
macroschizonts/ 
cell 
No. of cells with  
extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated  
    0 21.23±0.14 2.50±0.55 34.00±0.63 17.50±1.05 
 250 21.23±0.12 2.50±0.55 34.00±0.89 17.50±1.05 
 500  20.87±0.05* 2.50±0.55  24.00±0.63* 15.00±0.63* 
5000  19.90±0.89*   3.50±0.84*  11.00±0.63*  8.00±0.89* 
         10000  19.45±0.10*   5.83±0.75*  8.00±0.63*  4.50±0.55* 
 
*The mean difference is significant at the level 0.05 
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Table 6: Effect of aqueous extract of Gardenia ternifolia  
               on number of viable cells (m ±SD) 
Concentration  
ppm 
 
No. of cells x 104/ml 
48h. before 48 h. after 
   0 5.00±0.00 6.25±0.35 
250 5.00±0.00 6.25±0.35 
500 5.00±0.00 5.50±0.00* 
5000 5.00±0.00 4.25±0.00* 
           10000 5.00±0.00 3.50±0.00* 
 
*The mean difference is significant at the 0.05 level. 
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Fig. 16. Effect of aqueous extract of Gardenia ternifolia on  
              number of viable cells. 
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Fig. 17: Lymphoblast cell with vacuolated cytoplasm after 48h 
exposure to Gardenia ternifolia 
Giemsa stain (x1000) 
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3.5. Effect of Kigelia africana aqueous extract against  
       Theileria lestoquardi: 
3.5.1. Microscopic description:  
 The morphology of lymphoblast cells and macroschizonts 
48h after exposure to K. africana aqueous extract at 
concentrations 250, 500, 5000 and 10000ppm compared with the 
control was observed. Intact lymphoblast cells with dark, 
unrecognizable, degenerated schizonts were observed at concen-
trations 500, 5000 and 10000 ppm. Normal cells with normal 
macroschizonts at concentration 250 ppm were seen. Fig. 18 show 
lymphoblast cell with degenerated macroschizonts. 
3.5.2. Activity of K. africana aqueous extract against  
T. lestoquardi: 
 The activity of K. africana at concentration 250 ppm was 
zero, at concentrations 500, 5000 and 10000 ppm vary 
significantly (P<0.05) as compared with the control (Table 7 and 
Fig. 19). 
 LC50 and LC99 of K. africana aqueous extract were 2660.28 
ppm and 29980.34 ppm, respectively, were calculated from the 
linear regression line equation (Fig. 20).  
3.5.3. Mean number of macroschizonts per cell: 
 The effect of K. africana aqueous extract at concentrations 
250, 500, 5000 and 10000 ppm compared with the control is 
shown in Table 8. The mean number of macroschizonts at 
concentrations 500, 5000 and 10000 ppm decreased significantly 
(P<0.05) as compared with the control, at concentration 250ppm the 
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Fig. 18: Lymphoblast cell with degenerated macroschizonts after 
48h exposure to Kigelia africana 
Giemsa stain (x1000) 
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Table 7: Activity of aqueous extract of Kigelia africana 
               against T. Lestoquardi (m±SD) 
Concent. 
Ppm 
No. of cells with 
dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
Log con. 
       0 0.00±0.00 50.00±0.00 0.00±0.00 α 
   250 0.00±0.00 50.00±0.00 0.00±0.00 2.3979 
   500 10.00±0.63*  40.00±0.63* 20.00±1.26* 2.6290 
  5000 29.00±0.63*  21.00±0.63* 58.00±1.26* 3.6290 
10000 40.00±0.89* 10.00±0.89* 80.00±1.79* 4.0000 
 
*The mean difference is significant at the 0.05 level. 
Linear regression line (Fig. 20): Log con. 
y = a + bx 
y = -109.54+46.5892x 
Log LC50 =(50+109.54)/46.5892x=3.4249 
LC50 = Antilog 3.4249 =2660.284 
LC50 = 2660.28ppm 
Log LC99 =(99+109.54)/46.5892=4.4768 
LC99 = Antilog 4.4768=29980.339 
LC99=29980.34 ppm. 
 : No. of cells with dead macroschizonts (%) 
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mean number of macroschizonts was the same as the control. 
3.5.4. Mean number of lymphoblast cells with extra cellular  
macroschizonts: 
 The mean number of lymphoblast cells with extra cellular 
macrochizonts at concentrations 250, 500, 5000 and 10000 ppm 
was 2.5, 3.17, 5.5 and 8.33 (Table 8). There was significant 
increase (P<0.05) at concentrations 5000 and 10000ppm as 
compared with the control. 
3.5.5. Mean number of divided cells: 
 The mean number of divided cells (binucleated and 
multinucleated) is shown in Table 8. 
 The mean number of binucleated and multinucleated cells 
was the same as the control at concentration 250 ppm, decreased 
significantly (P<0.05) at concentrations 500, 5000 and 10000 
ppm.  
3.5.6. Mean number of viable cells:  
 The mean number of viable cells at concentrations 250, 
500, 5000 and 10000 ppm is presented in Table 9 and Fig. 21. The 
mean number of viable cells at concentration 250 ppm was the 
same as the control which increased insignificantly (P>0.05) 48h 
after incubation, at concentrations 500, 5000 and 10000 ppm 
decreased significantly (P<0.05) being 5.25x104, 4.00x104 and 
3.25x104 cells/ml, respectively. 
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Table 8: Effect of aqueous extract of K. africana on number of macroschizonts /cell,  
               cells with extra cellular macroschizonts and number of divided cells (m±SD) 
Concentration  
ppm 
No. of 
macroschizonts/ 
cell 
No. of cells with 
 extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated 
    0   21.23±0.14 2.50±0.55 34.00±0.63 17.50±1.05 
 250   21.23±0.08 2.50±0.55 34.00±0.89 17.50±1.22 
  500    20.50±0.089* 3.17±0.41 22.00±0.89* 13.00±0.89* 
 5000    19.50±0.23* 5.50±0.84* 10.00±0.89* 6.50±0.55* 
10000    18.70±0.14* 8.33±0.82* 6.00±0.63* 3.00±0.63* 
 
*The mean difference is significant at the level 0.05 
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Table 9: Effect of aqueous extract of Kigelia africana on  
               number of viable cells (m ±SD) 
Concentration  
ppm 
 
No. of cells x 104/ml 
48h before 48 h after 
    0 5.00±0.00 6.25±0.35 
250 5.00±0.00 6.25±0.35 
500 5.00±0.00 5.25±0.35* 
5000 5.00±0.00 4.00±0.00* 
           10000 5.00±0.00 3.25±0.35* 
 
*The mean difference is significant at the 0.05 level. 
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Fig. 21: Effect of aqueous extract of Kigelia africana on number 
   of viable cells. 
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3.5.7. Cytotoxicity of K. africana: 
3.5.7.1. Microscopic description: 
 Cytotoxicity of K. africana at concentration 10000ppm 
resulted in loss of cell aggregates, formation of cell debri and cells 
with variable size, some lymphoblast cells showed cyncetia and 
some lymphoblasts revealed necrotic nucleus (Fig. 22). 
3.5.7.2. Mean number of viable cells: 
 The mean number of viable cells decreased from 5x104 
cells/ml to 3.25x104 cells/ml after treatment with K. africana 
aqueous extract at concentration 10000 ppm whereas the 
untreated control increased insignificantly (P>0.05) to 6.25x104 
cells/ml. 
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Fig. 22:Lymphoblast cell revealed necrotic nucleus after 48h 
 exposure to Kigelia africanaGiemsa stain (x1000) 
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3.6. Effect of aqueous extract of Sonchus cornutus  against  
Theileria lestoquardi:  
3.6.1. Microscopic description: 
 The morphology of lymphoblast cells and macroschizonts 
48h after exposure to S. cornutus aqueous extract at 
concentrations 250 and 500 ppm were the same as the control. 
Normal, intact lymphoblast cells with pink, normal, recognizable, 
regular macroschizonts were observed. Beside normal cells, there 
were signs of cytotoxicity at concentrations 5000 and 10000 ppm. 
3.6.2. Activity of Sonchus cornutus aqueous extract: 
 The Activity of Sonchus cornutus aqueous extract at 
concentrations 250, 500, 5000 and 10000 ppm was zero, the same 
as the control (Table 10 and Fig. 23). This means that no activity 
against T. lestoquardi in vitro was found with S. cornutus. 
3.6.3. Mean number of macroschizonts per cell: 
 The mean number of macroschizonts per cell was not 
affected by S. cornutus aqueous extract at concentrations 250, 
500, 5000 and 10000 ppm (P>0.05) as compared with the control 
(Table 11). 
3.6.4. Mean number of lymphoblast cells with extra cellular  
macroschizonts: 
 The mean number of lymphoblast cells with extra cellular 
macroschizonts was the same as the control at concentrations 250, 
500 ppm, increased insignificantly (P>0.05) at concentrations 
5000 and 10000 ppm as compared with the control (Table 11). 
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Table 10: Activity of aqueous extract of Sonchus 
                cornutus  against T. Lestoquardi (m±SD) 
Concent. 
ppm 
No. of cells with 
dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
     0 0.00±0.00 50.00±0.00 0.00±0.00 
 250 0.00±0.00 50.00±0.00 0.00±0.00 
  500 0.00±0.00 50.00±0.00 0.00±0.00 
 5000 0.00±0.00 50.00±0.00 0.00±0.00 
10000 0.00±0.00 50.00±0.00 0.00±0.00 
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Fig. 23: Activity of aqueous extract of Sonchus 
 cornutus against T. lestoquardi. 
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Fig. 24: Linear regression line of aqueous extract 
             of  S. cornutus 
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3.6.5. Mean number of divided cells: 
 The mean number of divided cells (binucleated and multi-
nucleated) was the same as the control at concentrations 250 and 
500 ppm, decreased significantly (P<0.05) at concentrations 5000 
and 10000 ppm (Table 11). 
3.6.6. Mean number of viable cells: 
 The mean number of viable cells was not affected by S. 
cornutus aqueous extract at concentrations 250, 500 ppm but 
decreased significantly (P<0.05) at concentrations 5000 and 
10000 ppm as compared with the control which did not vary 
significantly (P >0.05) from the initial value (Table 12 and Fig. 
25). 
3.6.7. Cytotoxicity of S. cornutus: 
3.6.7.1. Microscopic description: 
 Concentrations 5000 and 10000 ppm resulted in cell debri, 
loss of cell aggregates, cells with variable size, cell with pyknotic 
dark nucleus (Fig. 26) and binucleated cell with vacuolated 
cytoplasm (Fig. 27).  
3.6.7.2. Number of viable cells: 
 Cytotoxicity of Sonchus cornutus decreased significantly 
(P<0.05) the mean number of viable cells at concentrations 5000 
and 10000 ppm compared with the control. 
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Table 11: Effect of aqueous extract of Sonchus cornutus on number of macroschizonts/cell,  
                 cells with extra cellular  macroschizonts and number of divided cells (m±SD) 
Concentration 
ppm 
No. of 
macroschizonts/ 
cell 
No. of cells with  
extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated 
    0  21.23±0.14 2.50±0.55 34.00±0.63 17.50±1.05 
 250 21.23±0.14 2.50±0.55 34.00±0.89 17.50±1.03 
 500 21.23±0.12 2.50±0.55  34.00±0.89 17.50±1.22 
             5000 21.23±0.10 2.83±0.75   9.00±0.89*    5.50±0.84* 
            10000 21.23±0.14 3.00±0.63  4.50±0.55*    3.50±0.55* 
 
*The mean difference is significant at the level 0.05 
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Table 12: Effect of aqueous extract of Sonchus cornutus  
                 on  number of viable cells (m±SD) 
Concentration  
ppm 
 
No. of cells x 104/ml 
48h before 48 h after 
   0 5.00±0.00 6.25±0.35 
250 5.00±0.00 6.25±0.35 
500 5.00±0.00 6.25±0.35 
5000 5.00±0.00 4.00±0.00* 
           10000 5.00±0.00 3.25±0.00* 
 
*The mean difference is significant at the 0.05 level. 
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  Fig. 25: Effect of aqueous extract of Sonchus cornutus on  
number of viable cells. 
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Fig. 26: Lymphoblast cell with pyknotic dark nucleus after 48h 
exposure to Sonchus cornutus 
Giemsa stain (x1000) 
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    Fig. 27: Lymphoblast cell with vacuolated cytoplasm after 48h 
exposure to Sonchus cornutus 
Giemsa stain (x1000) 
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3.7. Effect of aqueous extract of Tinospora bakis against  
       Theileria lestoquardi: 
3.7.1. Microscopic description: 
 The morphology of lymphoblast cells and macroschizonts 
treated with T. bakis aqueous extract at the concentrations 250 and 
500 ppm was the same as the control. Intra cellular dead 
macroschizonts at concentrations 5000 and 10000 ppm were dark 
in colour, irregular, unrecognizable with abnormal size. Fig. 28 
show degenerated macroschizonts. 
3.7.2. Activity of T. bakis: 
  The activity of T. bakis aqueous extract at concentrations 
250 and 500 ppm was the same as the control (zero) and increased 
significantly (P<0.05) at concentrations 5000 and 10000 ppm 
(Table 13 and Fig. 29) being 17.66% and 30.00%, respectively.  
LC50 and LC99 of T. bakis were calculated from the linear 
regression line equation (Fig. 30). LC50 and LC99 of T. bakis 
aqueous extract against T. lestoquardi were 184268.54 and 
84004796.85 ppm, respectively. 
3.7.3 Mean number of macroschizonts per cell: 
 The mean number of macroschizonts per cell at 
concentrations 250 and 500 ppm aqueous extract of T. bakis was 
the same as the control, decreased significantly (P<0.05) at 
concentrations 5000 and 10000 ppm being 20.6 and 20.3, 
respectively (Table 14). 
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    Fig. 28: Lymphoblast cell with degenerated macroschizonts 
after 48h exposure to Tinospora bakis 
Giemsa stain (x1000) 
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Table 13: Activity of aqueous extract of Tinospora bakis  
               against T. Lestoquardi (m±SD) 
Concent. 
ppm 
No. of cells with 
dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
Log con. 
     0 0.00±0.00 50.00±0.00 0.00±0.00 Α 
  250 0.00±0.00 50.00±0.00 0.00±0.00 2.3979 
  500 0.00±0.00 50.00±0.00 0.00±0.00 2.6990 
 5000   8.83±0.41*   41.17±0.41* 17.66±0.82* 3.6990 
10000 15.00±0.63*   35.00±0.63* 30.00±1.26* 4.0000 
 
*The mean difference is significant at the 0.05 level. 
Linear regression line (Fig.30): Log con. 
Linear regression equation: 
y = a + bx 
y = -47.037+18.429x 
Log LC50 =(50+47.037)/18.429=5.2655 
LC50 = Antilog 5.2655=184268.5384 
LC50 = 184268.54ppm 
Log LC99 =(99+47.037)/18.429=7.9243 
LC99 = Antilog 7.9243=84004796.85 
LC99=84004796.85ppm.  
 
 : No. of cells with dead macroschizonts (%) 
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Fig. 29: Activity of aqueous extract of Tinospora 
 bakis against T. lestoquardi 
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Fig. 30: Linear regression line of aqueous extract of  
Tinospora bakis 
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3.7.4. Mean number of lymphoblast cells with extra cellular  
macroschizonts: 
 The mean number of lymphoblast cells with extra cellular 
macroschizonts at concentrations 250 and 500 ppm was the same 
as the control, increased insignificantly (P>0.05) at concentration 
10000 ppm (Table 14). 
3.7.5. Mean number of divided cells: 
 Mean number of divided cells (binucleated and 
multinucleated cells) is shown in Table 14. The mean number of 
divided cells at concentrations 250 and 500 ppm was not affected, 
decreased significantly (P<0.05) at concentrations 5000 and 
10000 ppm (Table 14). 
3.7.6. Mean number of viable cells: 
 The effect of T. bakis aqueous extract on the number of 
viable cells is shown in Table 15 and Fig. 31. The mean number 
of viable cells 48h after exposure to T. bakis aqueous extract at 
concentrations 250 and 500 ppm was the same as the control 
(6.25x104 cells/ml), decreased significantly (P<0.05) at concentra- 
tions 5000 and 10000 ppm (5.25x104, 4.5x104 cells/ml). 
3.7.7. Cytotoxicity of T. bakis aqueous extract 
3.7.7.1. Microscopic description: 
 Some of the lymphoblast cells at concentration 10000 ppm 
of Tinospora bakis aqueous extract showed signs of cytotoxicity. 
Cytotoxic lymphoblast cell with vacuolated cytoplasm is shown in 
Fig. 32. 
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3.7.7.2. Mean number of viable cells: 
  The number of viable cells decreased significantly (P<0.05) 
at concentration 10000 ppm of Tinospora bakis aqueous extract.
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Table 14: Effect of aqueous extract of Tinospora bakis on number of macroschizonts/cell,  
                 cells with extra celllar macroschizonts and number of divided cells (m±SD) 
Concentration  
ppm 
No. of 
macroschizonts/ 
cell 
No. of cells with  
extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated  
    0 21.23±0.1.4 2.50±0.55 34.00±0.63 17.50±1.05 
250 21.23±0.12 2.50±0.55 34.00±0.89 17.50±0.84 
500 21.23±0.08 2.50±0.55 34.00±0.63 17.50±1.05 
             5000  20.60±0.09* 2.67±0.82  25.00±0.89*  13.50±1.05* 
            10000  20.30±0.09* 3.17±0.98  16.50±0.84* 11.00±0.89* 
 
*The mean difference is significant at the level 0.05 
 
98 
 
 
 
 
 
 
 
 
 
Table 15: Effect of aqueous extract of Tinospora bakis  
                 on  number of viable cells (m ±SD) 
Concentration  
ppm 
 
No. of cells x 104/ml 
48h before 48h after 
   0 5.00±0.00 6.25±0.35 
250 5.00±0.00 6.25±0.35 
500 5.00±0.00 6.25±0.35 
            5000 5.00±0.00 5.25±0.35* 
          10000 5.00±0.00 4.50±0.00* 
 
*The mean difference is significant at the 0.05 level. 
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Fig. 31. Effect of aqueous extract of Tinospora bakis on  
number of viable cells. 
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Fig. 32: Lymphoblast cell with vacuolated cytoplasm after 48h 
exposure to Tinospora bakis 
Giemsa stain (x1000)  
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3.8. Effect of Artemether 80 against Theileria lestoquardi: 
3.8.1. Microscopic description: 
 The morphology of lymphoblast cells and macroschizonts 
at concentration 0.01 mg/L was the same as the control. Dead 
macroschizonts at concentrations 0.10, 1.00 and 10.00 mg/L were 
dark in colour, unrecognizable, pyknotic. Fig. 33 show intact 
lymphoblast cell with necrotic macroschizonts. 
3.8.2. Activity of Artemether 80: 
 The activity of Artemether 80 at concentration 0.01 was 
zero, the same as the control, varied significantly (P<0.05) from 
the control at concentrations 0.10, 1.00 and 10.00 mg/L (Table 16 
and Fig. 34). 
LC50 and LC99 of Artemether 80 were 21.29 and 36829.85 
mg/L, respectively, were calculated from the linear regression line 
equation (Fig. 35). 
3.8.3. Mean number of macroschizonts per cell: 
 The mean number of macroschizonts per cell is shown in 
Table 17. The mean number of macroschizonts per cell at 
concentration 0.01 mg/L was the same as the control, decreased 
significantly (P<0.05) at concentrations 0.1, 1.0 and 10.0mg/L 
being 20.7, 20.2 and 19.73, respectively. 
3.8.4. Mean number of lymphoblast cells with extra cellular 
 macroschizonts: 
The mean number of lymphoblast cells with extra cellular 
macroschizonts at concentrations 0.01, 0.10 and 1.0 mg/L was not  
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Fig. 33: Lymphoblast cell with dark pyknotic macroshizonts after 
48h exposure to Artemether 80 
Giemsa stain (x1000) 
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Table 16: Activity of Artemether 80 against T. Lestoquardi  
                        (m±SD) 
Concent. 
mg/L 
No. of cells with 
dead 
macroschizonts 
No. of cells with 
alive 
macroschizonts 
No. of cells 
with dead 
macroschizonts 
(%) 
Log con. 
0.00 0.00±0.00 50.00±0.00 0.00±0.00 α 
0.01 0.00±0.00 50.00±0.00 0.00±0.00 -2.0 
0.10   7.00±0.00*   43.00±0.63*   14.00±1.27* -1.0 
1.00 15.17±0.00*   34.83±0.75*  30.34±1.50*  0.0 
   10.00 22.50±0.55*   27.50±0.55*  45.00±1.10* 1.0 
 
*The mean difference is significant at the 0.05 level. 
Linear regression line (Fig. 35): Log con 
Linear regression equation: 
y = a + bx 
y = 29.90+15.133x 
Log LC50 =(50+29.90)/ 15.133x =1.3282 
LC50 = Antilog 1.3282=21.29 
LC50 = 21.29mg/L 
Log LC99 =(99+29.90)/ 15.133 =4.5662 
LC99 = Antilog 4.5662=36829.854 
LC99=36829.85ppm.   
.: No. of cells with dead macroschizonts (%) 
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Fig. 34: Activity of Artemether 80 against T. lestoquardi 
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affected, increased significantly (P<0.05) from 2.5 to 3.67 at 
concentration 10.00 mg/L as compared with the control (Table 
17). 
3.8.5. Mean number of divided cells: 
 The mean number of divided cells (binucleated and 
multinucleated) is shown in Table 17. The mean number of 
binucleated and multinucleated cells was the same as the control at 
concentration 0.01 mg/L, decreased significantly (P<0.05) at 
concentrations 0.1, 1.0 and 10.0 mg/L as compared with the control. 
3.8.6. Mean number of viable cells: 
 The mean number of viable cells 48h after exposure to 
Artemether 80 is presented in Table 18 and Fig. 36. The mean 
number of viable cells did not change at concentration 0.01 mg/L, 
decreased insignificantly (P>0.05) at concentration 0.10 mg/L, but 
decreased significantly (P<0.05) at concentrations 1.0 and 10.0 
mg/L as compared with the control. 
3.8.7. Cytotoxicity of Artemether 80: 
3.8.7.1. Microscopic description: 
 Some cytotoxic lympoblast cells were observed at concen-
tration 10.0 mg/L. Fig. 37 show lymphoblast cell with vacuolated 
cytoplasm. 
3.8.7.2. Mean number of viable cells:  
The mean number of viable cells 48h after exposure to 
Artemether 80 at concentration 10.0 mg/L decreased  significantly 
(P<0.05) as compared with the control. 
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Table 17: Effect of Artemether 80 on number of macroschizonts / cell, cells  with extra  
                 cellular macroschizonts and number of divided cells (m±SD) 
Concentration  
mg/L 
No. of  
macroschizonts/ 
cell 
No. of cells with 
 extra cellular 
macroschizonts 
 
No. of divided cells 
Binucleated Multinucleated 
0.00 21.23±0.16 2.50±0.55 34.00±0.63 17.50±1.05 
0.01 21.23±0.15 2.50±0.55 34.00±0.89 17.50±0.63 
0.10 20.70±0.09* 2.50±0.55 28.00±0.63* 15.00±0.89* 
1.00 20.20±0.06* 2.83±0.75  20.00±1.10* 10.50±0.55* 
            10.00 19.73±0.08*   3.67±1.03*   15.00±0.63* 8.50±0.84* 
 
*The mean difference is significant at the level 0.05 
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Table 18: Effect of Artemether 80 on number of viable cells 
                 (m±SD) 
Concentration of 
Artemether 80  
mg/L 
 
No. of cells x 104/ml 
48h before 48 h after 
0.00 5.00±0.00 6.25±0.35 
0.01 5.00±0.00 6.25±0.35 
0.10 5.00±0.00 6.00±0.00 
1.00 5.00±0.00 5.25±0.35* 
10.00 5.00±0.00 4.25±0.00* 
 
*The mean difference is significant at the 0.05 level. 
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Fig. 36. Effect of Artemether 80 on number of viable cells. 
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 37: Lymphoblast cell with vacuolated cytoplasm after 48h 
exposure to Artemether 80 
Giemsa stain (x1000) 
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CHAPTER FOUR 
DISCUSSION 
 Theileria lestoquardi is morphologically and biologically 
similar to T. annulata (Kirvar et al., 1998) that is why the results 
were compared with T. annulata, because there was no 
information about T. lestquardi.  
 The results of the present study showed that buparvaquone 
at concentrations 0.01, 0.1, 1.0 and 10.0mg/L had high activities 
and its LC50 and LC99 were 0.000015 and 6.92mg/L, respectively, 
confirmed by the in vitro screening of buparvaquone done by 
McHardy et al. (1985) who found that the EC50 of buparvaquone 
against T. annulata was 16x10-9 M. Buparvaquone is the most 
active compound in the series of hydroxynaphthoquinones, which 
act on the parasite respiration by interfering with electron 
transport system (Dolan, 1981). 
 The number of viable cells per ml in infected untreated 
control after 48h incubation at 37oC increased (insignificantly) 
from 5.0x104 cells/ml to 6.25x104 cells/ml. On the other hand, 
McHardy (1978) found that the number of cells /ml in infected 
untreated control increased from 3.0x105 to 10.0x105 cell/ml. This 
is may reflect differences in growth rates due to inherent genetic 
and/or enviromental conditions, for example in the present study 
T. lestoquardi cell culture was used, supplemented with 20 
percent young calf serum, distributed in plastic tissue culture 
plates, sealed with sealing tape and incubated in an incubator not 
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supplied with Co2. On the other hand, McHardy (1978) used T. 
annulata cell culture, supplemented with 10% foetal calf serum, 
distributed in glass screw-capped tubes and incubated in 
atmosphere of 5% Co2 in air. Moulton et al. (1971a) who studied 
T. parva infected lymphoid cells in suspension culture used 20% 
foetal calf serum in the medium for growth of these cells and 
considered that the type and quantity of the serum were critical in 
their work.  
In the present studies, the number of T. lestoquardi viable 
cells treated with buparvaquone increased insignificantly from the 
initial value at concentrations 0.01 and 0.1 mg/L, inhibited at 
concentration 1.0mg/L and decreased to 4.5mg/L at concentration 
10.0 mg/L. These results showed significant difference (P<0.05) 
after 48 h when compared with the control. There was also clear 
microscopic evidence that buparvaquone killed  the  macroschizo- 
nts within the cell. There was positively correlation between the 
drug concentration and the mean number of dead macroschizonts 
per cell. The numbers of macroschizonts vary with strains of T. 
parva from different regions (Barnett et al., 1961). The number of 
divided cells (binucleated and multinucleated) significantly 
decreased as the concentration of buparvaquone increased. This is 
in line with Hulliger (1965) who stated that the parasite lives in 
perfect balance with its host cell, replicating within it and 
stimulating its multiplication as it is located in the Golgi 
apparatus. As a result of decrease in cell multiplication, the mean 
 
113 
number of viable cells/ml also decreased. This is in agreement 
with McHardy (1978) who reported that the rate of multiplication 
of T. annulata infected cells was markedly reduced as the parasite 
was eliminated. Also the number of cells with extra cellular 
macroschizonts increased significantly (P<0.05) as the 
concentration of buparvaquone increased. 
 Concentration of buparvaqnone at 10.0mg/L also caused 
cytopathic changes. Similar results were obtained by Moulton et 
al. (1971b) who reported that higher concentrations of the 
antibiotic caused cytopathic changes. 
 In the present investigations, 3 out of 4 natural products 
from local regions showed in vitro activity against T. lestoquardi 
schizonts in culture including Gardenia ternifolia, Kigelia 
africana and Tinospora bakis. Gardenia ternifolia aqueous extract 
showed activity of 13, 40 and 60% at concentrations 500, 5000 
and 10000 ppm, respectively, and LC50 of 6745.28ppm. These 
activities caused changes in the morphology of the dead 
macroschizonts in intact lymphoblast cells, significant decrease in 
the number of macroschizonts per cell, and increase in the number 
of cells with extra cellular macroschizonts at concentrations 5000 
and 10000 ppm. Also G. ternifolia caused decrease in the number 
of dividing cells and viable cells. However, G. ternifolia also 
showed cytotoxicity at concentrations 5000 and 10000 ppm. This 
was indicated by the changes that occurred in the morphology of 
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the lymphoblast cells and the significant decrease in the number 
of viable cells. 
 The results of the present study indicated that Kigelia  
africana aqueous extract had a high level of activity and its LC50 
was 2660.28 ppm. In previous studies with the malaria parasite 
Plasmodium falciparum, the most and great activity of K. africana 
proved to be 2-(1-hydroxyethyl)naphtho[2,3-b]furan-4,9-quinone, 
but isopinnatal 11 showed some activity. The activity is due to the 
increase of oxygen consumption and hydrogen peroxide 
production in the protozoal cell. Protozoa does not have 
biochemical mechanism as mammalian cells for dealing with 
excess oxygen free radical and so this process is used as a target 
for novel antiprotozoal compounds (Houghton, 2002). 
 The activity of K. africana against T. lestoquardi caused 
death of macroschizonts, change in their morphology and 
decreased their number per cell significantly at concentrations 
500, 5000 and 10000 ppm. Concentration 250ppm showed no 
activity. K. africana aqueous extract also reduced the rate of 
multiplication of cells which was clearly shown by the decrease in 
number of binucleated and multinucleated cells, but increased the 
number of cells with extra cellular macroschizonts due to its 
production of free oxygen radicals which are highly reactive and 
combine with lipid in the cell membrane of the cell to form 
peroxides. These peroxides are themselves very reactive and 
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cause disruption of the cell membranes and death of the cells 
(Lillehoj et al., 1970). 
Beside the high level of activity of K. africana aqueous 
extract there was cytotoxicity. This was evident by the cytopathic 
changes in the morphology of the macroschizonts and decrease in 
the level of viable cells from 5x104 to 4.00 and 3.25x104 cells/ml 
at concentration 5000 and 10000ppm compared with the infected 
untreated control cells which increased from 5x104 to 6.25x104 
cells/ml. This result is in line with Houghton (2002) who reported 
that the iridoid-related norviburtinal 5 and the napthoquinone 
isopinnatal extracted form Kigelia africana showed cytotoxic 
activity through the inhibition of mammalian cell lines growth. 
Ethanolic extracts of K. africana fruits had antitumour and little 
effect when administered intraperitoneally to mice at a dose of 
2mg, also khan and Mlungwana (1999) ascribed some in vitro 
cytotoxic activity of sitosterol 26 extracted from K. africana 
fruits.  
 No information about S. cornutus was recovered. However, 
some information were available for other species such as S. 
arvensis, S. oleraceus and S. transcaspicus. 
 In the present study, although S. cornutus lack activity 
against T. lestoquardi, it showed partial cytotoxicity at 
concentrations 5000 and 10000 ppm. Accordingly, there was no 
change in the morphology of the lymphoblast cells and 
macroschizonts at concentrations 250 and 500 ppm. The number 
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of macroschizonts per cell was not affected at all concentrations 
but the number of cells with extra cellular macroschizonts slightly 
increased at concentration 10000 ppm. However, the number of 
divided cells and viable cells decreased significantly (P<0.05) at 
concentrations 5000 and 10000 ppm. This is in line with Han et al 
(2005) who reported that S. transcaspicus showed in vitro 
cytotoxicity against cultured human hepatoma, human cervical 
carcinoma and murine melanoma cells.  Also S. oleraceus was 
mildly toxic as it may contain large quantities of nitrates 
(Leonard, 2007).  
 Screening of Tinospora bakis aqueous extract showed 
activity of 17.66% and 30% against T. lestoquardi at 
concentration 5000 and 10000ppm, respectively. This activity was 
low as compared with that of Buparvaquone. T. bakis contains 
palamtine isoquinoline alkaloid (Oliver-Beaver, 1968). On the 
other hand, Quattara et al. (2006) screened the aqueous extract of 
T. bakis roots for its antimalarial activity against P. falciparum. 
The authors found that LC50 of T. bakis was less than 50µg/ml. 
Lyophilized aqueous extract from the roots of T. bakis showed 
antipyretic activity at 300 and 600 mg/kg bodyweight when 
administered orally to hyperthermic rabbits as compared with 
aspirin as reference drug (Zafinindra et al., 2003). 
 The activity of T. babis at concentrations 5000 and 10000 
ppm caused abnormality in the morphology of dead 
macroschizonts, decrease in the number of macroschizonts per 
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cell, slight increase in the number of lymphoblast cells with extra 
cellular macroschizonts and significant decrease in the number of 
divided cells. The increase in activity was accompanied by a 
corresponding decline in the viability of the cell. 
 Beside the activity of T. bakis against T. lestoquardi there 
was partial cytotoxicity which caused morphological changes in 
the host cell and decrease in the viability of the cells at 
concentration 10000ppm. 
 The active constituents of Artemisia annua was isolated and 
characterized in 1972 as artemisinin, a sesquiterpene lactone with 
an unusual internal peroxide linkage (Hernandez et al., 1990). 
 The schizonticidal activity of Artemether is due to the 
destruction of asexual erythrocytic forms of P. falciparum and P. 
vivax. The antimalarial activity of Artemether is characterized by 
inhibition of the protein synthesis when trophozoites grow. Due to 
the similarity between the life cycle of theileria and plasmodium 
malaria, artemether 80 was screened for activity against T. 
lestoquardi. 
 The activity of Artemether 80 against T. lestoquardi at 
concentrations 0.1, 1.0 and 10.0mg/L was 14.00, 30.34 and 
45.00%, respectively with LC50 of 21.29 mg/L. On the other hand, 
the activity of A.absinthium against P. falciparum at concentration 
2.86 mg/ml was 89.8% (Hernandez et al., 1990).  
 Artemether 80 caused changes in the morphology of dead 
macroschizonts, which decreased significantly (P<0.05) at        
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concentrations 0.1, 1.0 and 10.0 mg/L, also the number of divided 
cells decreased, but the number of cells with extra cellular 
macroschizonts increased significantly at concentration 10.0 
mg/L. Accordingly, the number of viable cells per ml decreased 
significantly at concentration 10.0mg/L.  
 Artemether 80 beside its activity against T. lestoquardi at 
concentration 10.0 mg/L showed cytotoxicity. 
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Concluding Remarks: 
1. From this study (in vitro) it is clear that Kigelia africana is the  
    most active plant against Theileria lestoquardi.  
2. The highest activity of aqueous extract of Kigelia africana, 
Gardenia ternifolia and Tinospora bakis against Theileria 
lestoquardi was 80%,60% and 30%, respectively. 
3.  The highest activity of  aqueous extract of  Kigelia  africana, 
Gardenia ternifolia and Tinospora bakis at concentration 
10000ppm referring to the starting plant material aqueous 
extract. 
4. Sonchus cornutus aqueous extract lacks activity against 
Theileria lestoquardi.  
5. Kigelia  africana, Gardenia  ternifolia,  Tinospora bakis and 
 Sonchus cornutus extracts cause cytotoxicity as well. 
 
Recommendation: 
 It was  suggested that the future work is, however, 
necessary to elucidate the whole picture of the studied extracts 
including: 
1. Since the aqueous extracts of G. ternifolia, K. africana and 
Tinospora bakis showed activities against T. lestoquardi, 
biologically directed fractionation is recommended followed 
by isolation, structure determination and identification of the 
active compounds.  
2. In vivo study to confirm these results is important. 
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3. Toxicity of effective extracts to infected cells is an interesting 
observation that can be extended to antitumour research since 
T. lestoquardi infected cells are cancer-like transformed cells. 
4. Electron microscopy examination can be used for more details. 
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APPENDICES  
 
Appendix 1: Latin and vernacular (common) name(s) of the 
                     plants 
Latin Vernacular 
Allium sativum L. Elthoom; Eltoom, Basalmakada (Ar.); 
Garlic (En.). 
Aloe spp. Saba’ar, Elsabr (Ar.);  
Kalan’dowe (Had.) 
Artemisia absinthium Common wormwood, mugwort, sea 
wormwood and field worm wood 
Absinthe worm wood, worm wood, 
Grand worm wood (En.). 
Artemisia annua Sweet worm wood, Annie, Chinese 
wormwood (En.); Qinghao (Chinese) 
Artemisia spp. Elsheeh (Ar.) 
Alstonia Devil tree, Dita bark, Bitter bark (En.) 
Azadirachta indica A. Juss. Indian lilac, Margosa, Azadirach 
(En.); Neem (Ar. And En.). 
Cissus quadrangularis 
(Vitis quadrangularis) 
Sala’ala (Ar.); Tekwat’ako (Had.). 
Clematis simensis Shaaluk (Ar.). 
Clerodendrum myricoides Butter fly bush (En.) 
 
 
 
 
 Appendix 1:con. Latin and vernacular (common) name(s) of  
the plants 
Coleus barbatus 
(Plectranthus barbatus; 
Coleus forskohlii senu) 
Kalia ‘aya (Had.). 
Croton megalocarpus Croton (Ar. & En.) 
Hypericum revolutum Curry bush (En.). 
Iboza multiflora  Kiralankuba (Luganda); 
Kagayambulwa (Lusoga); Isejja, 
Kiraiga (Uganda) 
Khaya ivorensis African Mahogany (En.) 
Khaya senegalensis Mahogany; Senegal Mahogany (En.).
Lawsonia innermis (L. alba 
Lam.) 
Henna, Migonette Tree (En.). 
Lantana trifolia Shrub verbena (En.) 
Ocimum basilicum L.  
(O. lanceolatum) 
Alrehan, Alrehan El-Khalawie (Ar.); 
Common basil, sweet or Garden basil 
(En.). 
Pavetta schumanniana Poison brides bush (En.) 
Salvadora Persica L. ElArak, Araka, Shaui Muswak, 
Elswak (Ar.); Toothbrush Tree (En.). 
Sonchus arvensis Perennial sowthitle (En.). 
Sonchus oleraceus Moleita baladi (Ar.); Common or 
Smooth sowthistle (En.); Pualele 
(Hawai’i); sowthistle, hare’s thistle,  
 
Appendix 1:con. Latin and vernacular (common) name(s) of  
the plants 
 Pororua, Puwha, Puha (Maori); 
cerraja, serraja, diente de leon 
lechoso (colombia); Leche (Bolivia); 
Ilamp’u (Aymara); qarasapi 
(Quechua). 
 
  
 
 
Appendix Table 2: Effect of Buparvaquone on number of macroschizonts /cell, cells with extra cellular marcoschizonts and 
divided cells  
Slide No. Conc. mg/L 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 0.00 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2 0.00 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3 0.00 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4 0.00 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5 0.00 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6 0.00 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 0.01 18 19 19 18 19 17 18 19 19 19 18.5 4 25 15 
2 0.01 17 18 19 19 19 19 18 18 19 19 18.5 3 26 15 
3 0.01 18 19 18 19 19 19 19 19 19 19 18.8 3 26 14 
4 0.01 18 19 19 19 19 19 19 19 19 19 18.9 4 27 15 
5 0.01 19 17 17 18 18 19 19 19 19 18 18.3 3 25 13 
6 0.01 19 18 19 19 19 19 19 19 19 19 18.9 4 25 13 
Mean             18.65 3.50 25.67 14.17 
1 0.1 18 17 18 19 19 18 18 18 18 18 18.1 4 21 10 
2 0.1 18 18 18 18 18 18 18 18 18 18 18.0 3 19 9 
3 0.1 19 18 18 18 18 19 18 18 18 18 18.2 5 22 9 
4 0.1 18 18 19 18 17 18 18 18 18 18 18.0 4 20 11 
5 0.1 17 19 19 18 18 18 18 18 18 19 18.2 5 21 12 
6 0.1 18 18 18 18 19 18 18 18 18 17 18.0 4 20 9 
Mean             18.08 4.17 20.50 10.00 
 
Appendix Table 2: cont. Effect of Buparvaquone on number of macroschizonts /cell, cells with extra cellular 
marcoschizonts and divided  
                                          cells  
Slide 
 No. 
Conc. 
mg/L 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
aroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 1.0 17 17 17 17 18 17 17 17 17 17 17.1 6 16 7 
2 1.0 18 18 18 18 17 17 17 17 17 17 17.4 5 14 6 
3 1.0 17 18 18 18 18 17 17 17 17 17 17.4 6 15 8 
4 1.0 17 17 17 17 17 17 17 17 17 17 17.0 6 15 8 
5 1.0 18 18 17 17 17 17 17 18 18 18 17.5 5 16 6 
6 1.0 17 17 17 17 17 18 18 18 17 17 17.3 5 14 7 
Mean             17.28 5.5 15 7 
1 10.0 16 17 17 17 17 16 17 17 16 16 16.6 7 12 4 
2 10.0 16 16 17 17 17 17 17 16 17 17 16.7 8 13 6 
3 10.0 17 17 16 17 16 17 17 17 16 17 16.7 8 12 5 
4 10.0 16 15 16 17 17 17 17 17 17 16 16,5 7 11 5 
5 10.0 16 16 16 16 16 16 17 17 17 17 16.4 8 12 5 
6 10.0 16 17 17 17 17 17 16 16 16 16 16.5 7 12 5 
Mean             16.57 7.5 12 5 
 
 
 
 
 
Appendix Table 5: Effect of aqueous extract of Gardenia ternifolia  on number of macroschizonts /cell, cells with extra 
cellular  
                               macroschizonts and number of divided cells 
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1    0 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2    0 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3    0 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4    0 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5    0 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6     0 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 250 22 21 21 22 21 21 21 21 21 22 21.3 2 34 19 
2 250 20 21 21 23 22 23 21 21 20 20 21.2 3 34 18 
3 250 23 23 23 22 20 20 21 20 21 21 21.4 2 33 17 
4 250 21 21 21 21 20 20 21 22 22 22 21.1 2 33 18 
5 250 21 22 20 21 21 22 20 22 21 21 21.1 3 35 17 
6 250 23 21 22 22 21 20 20 21 20 23 21.3 3 35 16 
Mean             21.23 2.5 34 17.5 
1 500 21 20 22 21 20 20 20 21 22 22 20.9 3 23 15 
2 500 22 21 21 22 21 21 20 20 21 20 20.9 3 24 15 
3 500 21 21 21 20 21 21 21 21 20 21 20.8 2 25 15 
4 500 20 20 21 21 22 21 21 21 21 20 20.8 3 24 14 
5 500 21 22 21 21 21 21 20 20 21 21 20.9 2 24 16 
6 500 21 20 20 21 21 21 21 21 21 22 20.9 2 24 15 
Mean             20.87 2.5 24 15 
 
Appendix Table 5: cont. Effect of aqueous extract of Gardenia ternifolia  on number of macroschizonts /cell, cells with 
extra 
                                        cellular macroschizonts and number of divided cells 
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 5000 20 20 20 20 19 19 20 20 21 21 20.0 3 11 7 
2 5000 19 19 19 20 20 20 20 21 21 21 20.0 5 12 8 
3 5000 20 20 20 20 20 21 20 19 19 19 19.8 4 10 8 
4 5000 21 19 20 20 19 20 20 20 20 20 19.9 3 11 9 
5 5000 19 20 20 20 20 19 20 20 21 19 19.8 3 11 7 
6 5000 20 19 20 20 20 20 20 20 20 20 19.9 3 11 9 
Mean             19.90 3.50 11 8 
1 10000 19 19 20 19 19 19 19 20 20 19 19.3 7 8 4 
2 10000 20 19 19 19 20 19 20 19 19 20 19.4 5 9 5 
3 10000 21 19 19 19 19 19 19 20 20 20 19.5 6 8 4 
4 10000 21 20 20 19 20 20 19 19 19 19 19.6 6 7 4 
5 10000 19 19 19 20 19 19 20 20 20 20 19.5 6 8 5 
6 10000 20 20 19 19 20 20 19 19 19 19 19.4 5 8 5 
Mean             19.45 5.83 8 4.5 
 
 
Appendix Table 8: Effect of aqueous extract of Kigelia africana on number of macroschizonts/ cell, cells with extra cellular 
                                macroschizonts and number of divided cells  
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1     0 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2     0 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3     0 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4     0 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5     0 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6     0 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 250 22 21 20 21 21 21 21 21 22 22 21.2 3 35 19 
2 250 20 22 21 21 21 21 21 22 21 21 21.1 2 34 18 
3 250 23 21 21 21 21 21 22 21 21 21 21.3 3 33 16 
4 250 21 21 21 22 22 22 21 21 21 21 21.3 3 35 18 
5 250 21 20 22 21 21 20 21 22 21 23 21.2 2 33 18 
6 250 20 22 23 21 21 23 21 22 20 20 21.3 2 34 16 
Mean             21.23 2.5 34 17.5 
1 500 20 21 21 21 20 20 20 21 20 21 20.5 3 23 13 
2 500 22 21 20 20 20 21 21 20 21 20 20.6 3 21 14 
3 500 21 20 20 20 21 21 20 20 20 21 20.4 3 22 13 
4 500 20 21 21 20 20 20 20 20 21 22 20.5 3 22 12 
5 500 21 20 20 21 21 20 20 21 21 21 20.6 4 21 12 
6 500 22 20 20 20 20 20 21 21 20 20 20.4 3 23 14 
Mean             20.50 3.17 22 13 
 
Appendix Table 8: cont. Effect of aqueous extract of Kigelia africana on number of macroschizonts/ cell, cells with extra 
cellular 
                                         macroschizonts and  number of divided cells 
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 5000 19 19 20 20 20 19 19 19 20 19 19.4 5 9 7 
2 5000 19 20 20 20 20 19 19 20 20 20 19.7 5 11 6 
3 5000 21 19 20 19 19 20 20 20 20 20 19.8 5 10 7 
4 5000 20 20 19 19 20 20 20 19 19 19 19.5 7 10 7 
5 5000 19 19 20 20 19 19 19 20 20 20 19.5 5 11 6 
6 5000 19 20 19 19 19 19 19 19 19 19 19.1 6 9 6 
Mean             19.5 5.50 10 6.5 
1 10000 18 19 19 19 19 19 19 19 19 19 18.9 9 6 3 
2 10000 19 19 17 19 19 19 19 19 19 19 18.8 7 7 2 
3 10000 18 19 19 19 18 19 19 19 19 18 18.7 9 6 4 
4 10000 19 19 19 17 18 19 19 19 19 19 18.7 8 6 3 
5 10000 19 18 19 19 19 19 18 19 18 17 18.5 8 6 3 
6 10000 18 18 19 18 19 19 19 19 19 18 18.6 9 5 3 
Mean             18.7 8.33 6 3 
 
Appendix Table 11: Effect of aqueous extract of Sonchus cornutus on number of macroschizonts/ cell, cells with extra 
cellular 
                                  macroschizonts and  number of divided cells 
Slide  
No. 
Conc. 
Ppm 
No. of macroschizonts per cell 
 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1    0 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2    0 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3    0 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4    0 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5    0 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6    0 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 250 23 21 21 22 21 21 20 21 21 23 21.4 3 33 18 
2 250 21 20 20 21 22 22 21 22 21 21 21.1 2 33 18 
3 250 20 22 21 21 20 21 21 20 22 22 21.0 3 35 18 
4 250 22 21 22 21 21 21 21 21 22 22 21.4 2 34 18 
5 250 20 23 21 20 23 20 23 22 21 20 21.3 2 35 17 
6 250 23 21 21 22 21 21 20 21 21 21 21.2 3 34 16 
Mean             21.23 2.5 34 17.5 
1 500 21 21 22 21 21 22 21 21 22 21 21.3 3 33 19 
2 500 23 21 20 21 22 21 22 20 21 20 21.1 2 35 16 
3 500 21 21 21 21 21 21 21 21 21 22 21.1 3 34 17 
4 500 22 22 22 20 21 20 22 22 22 21 21.4 2 35 17 
5 500 21 20 21 22 22 23 21 21 20 22 21.3 3 34 17 
6 500 21 21 22 21 21 21 21 21 22 21 21.2 2 33 19 
Mean             21.23 2.5 34 17.5 
 
Appendix Table 11: cont. Effect of aqueous extract of Sonchus cornutus on number of macroschizonts/ cell, cells with extra 
                                          cellular macroschizonts and  number of divided cells 
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 5000 22 22 21 20 21 21 21 21 21 22 21.2 2 9 5 
2 5000 21 21 22 21 21 23 20 20 20 23 21.2 3 8 6 
3 5000 23 21 21 23 20 21 22 21 21 20 21.3 4 8 7 
4 5000 20 21 22 21 22 20 21 21 22 21 21.1 2 10 5 
5 5000 21 22 21 20 21 21 23 22 21 22 21.4 3 10 5 
6 5000 22 23 20 22 20 20 21 20 22 22 21.2 3 9 5 
Mean             21.23 2.83 9 5.5 
1 10000 21 21 21 21 21 21 23 21 21 21 21.2 3 4 3 
2 10000 21 22 21 22 21 20 21 21 21 20 21.0 4 5 4 
3 10000 23 20 22 20 21 21 20 21 22 22 21.2 3 4 4 
4 10000 22 21 20 22 20 22 22 21 22 21 21.3 3 5 3 
5 10000 20 20 21 23 21 21 21 23 21 22 21.3 2 5 3 
6 10000 21 21 22 21 20 22 21 22 21 23 21.4 3 4 4 
Mean             21.23 3 4.5 3.5 
 
 
Appendix Table 14: Effect of aqueous extract of Tinospora bakis on number of macroschizonts/ cell, cells with extra 
cellular 
                                 macroschizonts and  number of divided cells 
Slide 
 No. 
Conc. 
ppm 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1    0 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2     0 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3     0 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4     0 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5     0 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6     0 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 250 22 21 21 22 21 21 21 21 21 22 21.3 3 33 18 
2 250 20 20 21 23 22 23 21 21 21 20 21.2 2 35 17 
3 250 23 23 23 22 20 20 21 20 21 21 21.4 2 34 19 
4 250 21 21 21 21 20 20 21 22 22 22 21.1 2 35 17 
5 250 21 22 20 21 21 22 20 22 21 21 21.1 3 34 17 
6 250 23 21 22 22 21 20 20 21 20 23 21.3 3 33 17 
Mean             21.23 2.5 34 17.5 
1 500 22 21 21 21 22 21 22 21 21 21 21.3 3 34 16 
2 500 21 22 22 21 21 22 21 22 20 21 21.3 3 35 17 
3 500 21 21 21 21 21 21 22 21 21 23 21.3 2 34 17 
4 500 20 21 21 22 21 21 21 21 21 22 21.1 2 34 18 
5 500 22 21 21 21 21 21 21 22 21 21 21.2 2 34 19 
6 500 21 22 21 21 22 21 22 21 21 20 21.2 3 33 18 
Mean             21.233 2.5 34 17.5 
 
Appendix Table 14: cont. Effect of aqueous extract of Tinospora bakis on number of macroschizonts/ cell, cells with extra 
cellular 
                                           macroschizonts and  number of divided cells 
Slide  
No. 
Conc. 
ppm 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 5000 20 21 21 21 21 21 21 20 21 20 20.7 3 25 14 
2 5000 21 21 20 21 20 20 20 21 20 21 20.5 2 24 13 
3 5000 22 20 21 20 20 20 21 21 20 21 20.6 3 26 12 
4 5000 21 19 20 21 21 21 21 20 20 21 20.5 4 25 13 
5 5000 20 21 21 20 21 21 21 21 21 19 20.6 2 24 14 
6 5000 19 21 21 21 21 21 20 21 21 21 20.7 2 26 15 
Mean             20.6 2.67 25 13.5 
1 10000 20 20 19 21 20 20 21 20 20 21 20.2 4 17 11 
2 10000 21 21 20 21 20 20 20 20 21 20 20.4 3 16 10 
3 10000 20 19 19 21 21 20 20 21 21 21 20.3 2 17 12 
4 10000 21 20 20 20 20 21 20 20 20 20 20.2 2 17 11 
5 10000 21 19 20 20 20 20 20 21 21 21 20.3 4 15 12 
6 10000 20 21 21 19 21 21 21 19 20 21 20.4 4 17 10 
Mean             20.3 3.17 16.5 11 
 
Appendix Table 17: Effect of Artemether 80 on number of macroschizonts/ cell, cells with extra cellular macroschizonts 
and  number  
                                of  divided cells  
Slide  
No. 
Conc. 
mg/L 
No. of macroschizonts per cell 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 0.00 22 22 21 22 21 20 22 21 22 20 21.3 2 34 17 
2 0.00 23 21 20 21 22 23 22 20 20 20 21.2 2 35 18 
3 0.00 22 23 20 23 22 20 21 22 20 21 21.4 3 34 19 
4 0.00 24 21 22 20 21 21 21 22 20 20 21.2 3 33 17 
5 0.00 20 20 23 21 23 21 21 20 21 20 21.0 2 34 18 
6 0.00 21 23 23 20 21 20 21 22 21 21 21.3 3 34 16 
Mean             21.23 2.5 34 17.5 
1 0.01 22 22 21 22 21 20 22 21 22 20 21.3 3 35 18 
2 0.01 23 21 20 21 22 23 23 20 20 20 21.3 3 33 17 
3 0.01 22 23 20 23 22 20 21 22 20 21 21.4 2 33 19 
4 0.01 23 21 22 20 21 21 21 22 20 20 21.1 2 33 17 
5 0.01 20 20 23 21 23 21 21 20 21 20 21.0 3 35 17 
6 0.01 21 23 23 20 21 20 21 22 21 21 21.3 2 35 17 
Mean             21.23 2.5 34 17.5 
1 0.1 20 21 20 20 21 21 21 21 21 21 20.7 3 28 16 
2 0.1 21 21 21 21 21 19 19 21 21 21 20.6 2 28 14 
3 0.1 20 20 21 21 21 20 20 21 21 21 20.6 2 27 15 
4 0.1 21 21 21 21 20 20 21 21 21 21 20.8 2 28 16 
5 0.1 20 20 20 21 21 21 21 21 21 21 20.7 3 29 15 
6 0.1 19 21 21 21 21 21 21 21 21 21 20.8 3 28 14 
Mean             20.7 2.5 28 15 
 
 
Appendix Table 17: cont. Effect of Artemether 80 on number of macroschizonts/ cell, cells with extra cellular 
macroschizonts  
                                           and number of divided cells 
Slide  
No. 
Conc. 
Mg/L 
No. of macroschizonts per cell 
 
Cell No. Mean  
N
o of cells w
ith 
extra cellular 
m
acroschizonts 
No. of divided cells  
1 2 3 4 5 6 7 8 9 10 Binucleated Multi-
nucleated 
1 1.0 20 20 21 21 20 20 20 20 20 20 20.2 3 21 11 
2 1.0 21 19 19 20 20 20 21 21 21 21 20.3 2 21 10 
3 1.0 19 21 21 20 19 20 21 21 21 19 20.2 2 20 10 
4 1.0 21 20 20 19 19 20 20 21 21 21 20.2 3 20 10 
5 1.0 20 20 21 21 21 19 20 20 20 20 20.2 3 18 11 
6 1.0 21 20 20 20 20 20 20 19 20 21 20.1 4 20 11 
Mean             20.2 2.83 20 10.5 
1 10.0 20 19 20 20 20 20 20 20 19 20 19.8 5 14 9 
2 10.0 18 20 20 20 20 20 20 20 20 20 19.8 4 15 9 
3 10.0 20 20 18 20 20 19 20 20 20 19 19.6 2 15 8 
4 10.0 20 20 20 18 20 20 20 19 20 20 19.7 4 15 7 
5 10.0 19 20 20 20 20 20 20 20 18 20 19.7 3 16 9 
6 10.0 20 20 20 20 20 19 20 20 20 19 19.8 4 15 9 
Mean             19.73 3.67 15 8.5 
 
 
 
 
 
 
